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Transcriptional analysis of abdominal fat in
chickens divergently selected on
bodyweight at two ages reveals novel
mechanisms controlling adiposity:
validating visceral adipose tissue as a
dynamic endocrine and metabolic organ
C. W. Resnyk1, W. Carré1,2†, X. Wang1,3†, T. E. Porter4, J. Simon5, E. Le Bihan-Duval5, M. J. Duclos5, S. E. Aggrey6
and L. A. Cogburn1*

Abstract
Background: Decades of intensive genetic selection in the domestic chicken (Gallus gallus domesticus) have enabled the
remarkable rapid growth of today’s broiler (meat-type) chickens. However, this enhanced growth rate was accompanied
by several unfavorable traits (i.e., increased visceral fatness, leg weakness, and disorders of metabolism and reproduction).
The present descriptive analysis of the abdominal fat transcriptome aimed to identify functional genes and biological
pathways that likely contribute to an extreme difference in visceral fatness of divergently selected broiler chickens.
Methods: We used the Del-Mar 14 K Chicken Integrated Systems microarray to take time-course snapshots of global
gene transcription in abdominal fat of juvenile [1-11 weeks of age (wk)] chickens divergently selected on bodyweight
at two ages (8 and 36 wk). Further, a RNA sequencing analysis was completed on the same abdominal fat samples
taken from high-growth (HG) and low-growth (LG) cockerels at 7 wk, the age with the greatest divergence in body
weight (3.2-fold) and visceral fatness (19.6-fold).
Results: Time-course microarray analysis revealed 312 differentially expressed genes (FDR ≤ 0.05) as the main effect of
genotype (HG versus LG), 718 genes in the interaction of age and genotype, and 2918 genes as the main effect of age.
The RNA sequencing analysis identified 2410 differentially expressed genes in abdominal fat of HG versus LG chickens
at 7 wk. The HG chickens are fatter and over-express numerous genes that support higher rates of visceral adipogenesis
and lipogenesis. In abdominal fat of LG chickens, we found higher expression of many genes involved in hemostasis,
energy catabolism and endocrine signaling, which likely contribute to their leaner phenotype and slower growth. Many
transcription factors and their direct target genes identified in HG and LG chickens could be involved in their divergence
in adiposity and growth rate.
(Continued on next page)
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Conclusions: The present analyses of the visceral fat transcriptome in chickens divergently selected for a large
difference in growth rate and abdominal fatness clearly demonstrate that abdominal fat is a very dynamic
metabolic and endocrine organ in the chicken. The HG chickens overexpress many transcription factors and
their direct target genes, which should enhance in situ lipogenesis and ultimately adiposity. Our observation
of enhanced expression of hemostasis and endocrine-signaling genes in diminished abdominal fat of LG
cockerels provides insight into genetic mechanisms involved in divergence of abdominal fatness and somatic
growth in avian and perhaps mammalian species, including humans.
Keywords: Divergent genetic selection, Gene expression, Microarray analysis, RNA-Seq analysis, Adiposity, Lipogenesis,
Transcriptional regulation, Hemostasis genes, Endocrine signaling

Background
The domestic chicken (Gallus gallus domesticus) is a
widely used biomedical model and serves as a major
source of high-quality dietary protein for humans.
Decades of intensive genetic selection have led to the
remarkable growth rate and feed efficiency of
commercial broiler chickens. However, this rigorous
genetic selection for growth rate has led to increased
adiposity, skeletal abnormalities, and disorders of metabolism and reproduction [1–4]. Few studies have
attempted to identify biological pathways and gene
networks that promote abdominal fatness and related
metabolic disorders in the chicken. Previous studies
of global gene transcription in different models of
chicken growth have concentrated on either skeletal
muscle [5] or the hypothalamus [6] for identification
of candidate genes responsible for differences in
growth rate. Another study compared intra-muscular
adipose tissue between two lines of chickens selected
for fast growth or slow growth [7]. This microarray
analysis showed that expression of several differentially expressed (DE) genes was correlated with increased or decreased growth of breast muscle and
intramuscular fat, which suggests that adipose tissue
per se could regulate the rate of muscle growth, albeit
no mechanisms related to abdominal fatness were
uncovered.
A large volume of research has been published on
growth and metabolic characteristics of the Virginia
Tech (VT) population [8, 9] of chickens, which were
divergently selected on body weight at 56 days of age (8
wk) [10–19]. The VT low-weight strain (LWS) chickens
exhibit diminished growth, anorexia [15], impaired
endocrine signaling [13, 15, 19, 20], and higher expression of genes involved in catabolism of lipid [17]. A genomic scan of the VT high-weight (HWS) and low-weight
(LWS) selected chickens revealed several quantitative
trait loci (QTL) and their associated polymorphic genes
related to divergent selection for body weight at 8 wk
[9]. Among the candidate genes identified by combined
analyses of genome sequence variation in the VT HWS

and LWS chickens were glucagon (GCG), insulin-like
growth factor binding protein-2 (IGFBP2) and
endothelin-1 (EDN1). Furthermore, we found that these
three genes (GCG, IGFBP2 and END1) were differentially expressed in abdominal fat of genetically fat (FL)
and lean (LL) chickens [21, 22]. Our transcriptional
study of abdominal fat in the FL and LL chickens also
revealed over-expression of numerous lipogenic genes in
the FL, which suggests that adipose tissue has a more
significant involvement in the synthesis and metabolism
of lipids than previously thought [21]. More importantly,
we discovered over-expression of an unusually large
number of genes involved in hemostasis, endocrine
signaling and lipid catabolism [22] in the diminished
abdominal fat of LL chickens.
The present study focuses on the transcriptional analysis of abdominal fat in a random-bred population of
Bresse-Pile (meat-type) chickens, which were divergently
selected by Ricard [23] for either high growth (HG) or
low growth (LG) body weight at two developmental ages
[juvenile (8 wk) and adult (36 wk)]. The diverse growth
curves [24] and muscle growth patterns [25–29] of the
HG and LG chickens have been described in detail.
These unique growth models were chosen for our original functional genomics project aimed at identification
of genomic regions and gene networks, which control
growth and metabolism of the broiler chicken [30–32].
Despite genetic selection for a large difference in bodyweight (3.2-fold at 7 wk), these divergent lines exhibit an
even greater difference in abdominal fat weight
(19.6-fold at 7 wk). Furthermore, we have published several papers from quantitative trait loci (QTL) analyses
using the F2 resource population created from an intercross of HG and LG chickens [33–36]. These genetic
analyses have revealed numerous genomic loci containing positional candidate genes associated with several
metabolic and growth traits. Another study of this
unique F2 resource population has identified a cis
expression QTL (eQTL) controlling β-carotene 15,
15′-monooxygenase (BCMO1) expression, which consequently determines the extent of yellow coloring in
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chicken breast muscle, an important meat quality trait
[37]. The LG chickens, which carry the inactive BCMO1
gene, exhibit a slower growth rate, greatly-reduced abdominal (visceral) fatness, lower plasma insulin, and
hyperglycemia when compared to the HG chickens [34].
Thus, the present study aimed to identify differential gene expression in abdominal fat of HG and LG
chickens, which show a greater divergence in abdominal fatness that is incidental to their selection on
body weight at two ages (juvenile and adult). Our
analyses reveal overexpression of genes in abdominal
fat of the HG birds that are involved in increased
adiposity, including transcriptional regulators and
metabolic (lipogenic) enzymes, throughout juvenile
development (1-11 wk). Conversely, LG chickens
shown up-regulation of several energy generating
processes (i.e., peroxisomal β-oxidation, mitochondrial
β-oxidation, ketogenesis and oxidative phosphorylation) early in juvenile development which are likely
responsible for their extreme leanness. The RNA-Seq
analysis of abdominal fat at 7 wk. revealed up-regulation of several hemostatic factors in the LG cockerels
that could contribute to their extreme leanness. Furthermore, this transcriptional study of visceral adiposity in HG and LG meat-type (Bresse-Pile) chickens
also serves as cross-validation of abdominal fat as a
dynamic endocrine and metabolic organ as indicated
in our genetically fat (FL) and lean (LL) chicken lines
[21, 22].

Methods
Animal management and tissue preparation

The chickens used in this study were divergently selected from a population of Bresse-Pile (meat-type)
chickens by Ricard [23, 38] for an extreme difference in
body weight at two ages: 8 (juvenile) and 36 (adult)
weeks of age (wk). Chickens were bred and raised at
INRA UE1295 Pôle d’Expérimentation Avicole de Tours,
F-37380, Nouzilly, France. At hatching, HG and LG
cockerels were wing-banded and vaccinated against
Marek’s disease virus. Birds were provided with ad
libitum access to water and fed a conventional starter ration (22% crude protein and 3050 kcal ME/kg) from
hatching to 3 wk and then with a grower pelleted ration
from 3 to 11 wk. (20% crude protein, and 3100 kcal).
The HG birds were separated from LG birds for the first
3 weeks (at which time LG chickens were provided
crushed feed pellets) to increase early survival of the LG;
afterwards, both lines were placed together and raised in
floor pens (4.4 m × 3.9 m). Continuous incandescent
light was provided for the first two days followed by a
maintenance of a 14 h light /10 h dark cycle (14 L:10D).
Infrared gas heaters provided supplemental heat and the
ambient temperature was decreased progressively from
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32 °C at hatching, until 22 °C was reached at 22 days. At
1, 3 5, 7, 9 and 11 wk, eight fed cockerels from each genetic line (HG and LG) were randomly selected, weighed
and bled into heparinized syringes prior to cervical dislocation, and the excision and weighing of abdominal fat
mass. Abdominal adipose tissue samples were immediately snap frozen in liquid nitrogen and stored at −75° C
until further processing for RNA analysis.

Transcriptional analysis
RNA extraction

Abdominal fat aliquots from forty-eight individuals (4 HG
and 4 LG per age at 1, 3, 5, 7, 9 and 11 wk) were homogenized and total cellular RNA extracted using guanidine
thiocyanate and CsCl gradient purification [39], followed by
DNase I treatment. The quality of RNA was determined
with an RNA 6000 Nano Assay kit and the Model 2100
Bioanalyzer (Agilent Technologies; Palo Alto, CA). All samples used for RNA analyses had an RNA integrity number
(RIN) greater than 9.0.
Microarray analysis and statistical analysis of microarray
data

The Del-Mar 14 K Chicken Integrated Systems Microarrays (Geo Platform # GPL1731) described earlier [31]
were used for transcriptional profiling of four abdominal
fat samples from each genotype (HG and LG), across
11 weeks of juvenile development (48 total individuals).
Methods used for microarray preparation including
labeling, hybridization, and image acquisition were
described earlier [21]. Briefly, twenty-four Del-Mar 14 K
Chicken Integrated Systems Microarrays were hybridized
with 48 labeled samples using a balanced block design
[40], where half of the birds from each genotype and age
were labeled with Alexa Flour® 647 (red dye) and the
other half with Alexa Flour® 555 (green dye); see
Additional file 1 for experimental design. These hybridized microarrays were scanned with a GenePix 4000B
scanner using GenePix Pro 4.1 software (Molecular
Devices, Union City, CA) at wavelengths of 635 nm
(Alexa® 647-labeling) and 532 nm (Alexa® 555-labeling)
producing a combined TIFF image file for each slide.
Laser power was set at 100% with the photomultiplier
tube (PMT) setting adjusted for each scan producing a
PMT count near unity. All slides were checked manually
for quality, and all spots with inadequacies in signal,
background or morphology were eliminated. The image
analysis results were merged with Excel files (in GPR
format) containing clone identification, spot location on
slide, and most current gene name/function (based on
BLAST score). The gene list were first annotated by
clone ID, GenBank ID as determined by BLASTN or
BLASTX analysis using the GeneBase function on our
laboratory website [41].
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The GPR files were used to determine differential
expression in abdominal fat of HG and LG chickens.
Log2 transformed median intensity values (for each dye)
were normalized using a global LOWESS transformation
(without background subtraction) to remove dye bias
within microarray [42]. A two-way ANOVA was used to
determine main effects of age (A) and genotype (G), and
interactions between age and genotype (A x G); differences between genotypes at each age were also determined. The Benjamini-Hochberg procedure [43] was
used to control experiment-wise false discovery rate
(FDR) associated with multiple testing. The differentlyexpressed (DE) gene lists from the time course (1-11
wk) microarray analysis were functionally annotated
using the GeneBase function on our laboratory website
[41] and finally the Ingenuity Knowledge Base [44].
Expression values of 25 DE genes at 7 wk were retrieved
from the microarray analysis for comparison across the
three methods. For these 25 genes, a Student’s T-test
was used to determine significant differences between
genotypes.
RNA-sequencing and statistical analyses

The same eight RNA samples (4 HG and 4 LG at 7 wk),
originally used for the microarray analysis, were also
used for construction of indexed (bar-coded) sequencing
libraries. Libraries were made from 2 μg of total adipose
RNA with the Illumina TruSeq® Stranded mRNA library
preparation kit following standard Illumina protocols.
All eight barcoded libraries were pooled and paired-end
sequenced (101-bp reads) in duplicate lanes on an
Illumina HiSeq 2000 Sequencing System (Illumina, Inc.,
San Diego, CA) at the Delaware Biotechnology Institute,
University of Delaware (Newark, DE).
Sequences were trimmed for quality using a combination of custom Perl scripts and Btrim64 software [45].
Boxplot graphing of pre-and-post trimming reads
confirmed the absence of outlier samples based on read
count. After trimming, reads were mapped to the
chicken genome assembly Galgal4.0 (down-loaded from
Ensembl) using Tophat (version 1.3.3), followed by assembly and quantitation using Cufflinks software
(v1.3.0). The fragments per kilobase of exon per million
fragments mapped (FPKM) threshold for detection of a
gene was set at FPKM > 0.5. The resulting gtf files were
merged with cuffmerge, and differential expression was
assessed using Cuffdiff. The two-sided P-value was
corrected using the false discovery rate (FDR) which
accounts for multiple testing procedures [43]. Genes
with a FDR adjusted P-value (P ≤ 0.05) and fold change
≥ 1.2 were considered to be differentially expressed (DE)
transcripts. This detection threshold was based on our
extensive transcriptional analyses of multiple tissues in
the chicken.
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Ingenuity Pathway Analysis of differentially expressed
genes from microarray and RNA-Seq analyses

Differentially-expressed (DE) gene datasets from the
time-course microarray analyses were submitted to
Ingenuity® Pathway Analysis (IPA) [44] for functional
annotation as “Analysis Ready” (AR) genes according
to annotated mammalian genes and proteins accrued
in the Ingenuity® Knowledge Base. The unique and
commonly shared (intersect) gene sets were then used
for Ingenuity Up-Stream Regulator analysis to identify
transcription factors and their direct target genes.
Quantitative RT-PCR analysis

Candidate DE genes were selected for verification of expression by quantitative RT-PCR (qRT-PCR) analysis
from both the time-course microarray analysis (1-11 wk)
and RNA-Seq analysis (7 wk). Superscript III reverse
transcriptase (Invitrogen) and an oligo (dT) primer were
used to prepare cDNA from 1 μg of RNA. Primers were
designed using Primer Express v2.0 software (Applied
Biosystems, Foster City, CA). Detailed information for
each primer pair including gene name, gene symbol,
primer sequences (forward and reverse), GenBank
accession number and amplicon size is provided in
Additional file 2.
The qRT-PCR assays were performed in an ABI
Prism Sequence Detection System 7900HT using
50 ng of cDNA, Power SYBR green PCR master mix
(Applied Biosystems, Foster City, CA) and 400 nM of
each primer (forward and reverse; Sigma-Aldrich, St.
Louis, MO) in duplicate wells. Disassociation curves
were analyzed to confirm specific amplification and to
verify absence of primer dimers. Resulting PCR products were subjected to agarose gel electrophoresis to
compare PCR product size to expected amplicon size.
To verify gene expression from the microarray and
RNA-Seq analyses, the cycle time (Ct) for each
sample was normalized to the corresponding sample
geometric mean of two housekeeping genes: cytochrome c oxidase subunit VIIa polypeptide 2 like
(COX7A2L) and ribosomal protein L14 (RPL14). The
housekeeping genes were selected based on invariability in the microarray and RNA-Seq analyses. Their
stable expression in qRT-PCR analysis was
determined by Biogazelle qbase+ software [46]. The 2(ΔΔCt)
formula was used to calculate relative transcript
abundance [47]. The statistical analysis was performed
using a general linear model procedure in SAS v9.3
and differences between genotypes at each age were
determined using Tukey’s multiple comparisons test.
For genes only analyzed at 7 wk., a Student’s T-test
was used to detrmine differential expression. The
significance level for statistical analysis was set at
P ≤ 0.05.
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Independent bioinformatic analysis of RNA-Seq analyses
of abdominal fat across four divergent genotypes

An independent analysis was conducted on two deposited RNA-Seq datasets of abdominal fat (7 wk) in
four distinct genotypes/phenotypes, which were created by divergent genetic selection on juvenile and
adult BW (HG vs. LG; NCBI GEO Series Accession #
GSE49121) or abdominal fatness at the same BW [fat
line (FL) vs. lean line (LL); NCBI GEO Series
Accession # GSE42980)]. The systems biology analysis
of these two RNA-Seq datasets was performed by the
Animal Systems Biology Analysis and Modeling
Center (ASBAMC), University of California at Davis,
CA. The components of the custom bioinformatics
pipeline used for systems biology analysis of domestic
animals are described in detail on the project website
[48]. The main purpose of this independent metaanalysis of abdominal fat transcriptomes across four
distinct genotypes (HG-LG; FL-LL) at the same age (7
wk) was to identify a set of common and unique DE
gene across the four genotypes for further functional
and pathway analyses using IPA.

Results
Phenotypic measurements

Body weight (BW) and relative abdominal fatness
(%BW) of juvenile HG and LG chickens are presented in
Fig. 1. On average, the HG cockerels were 2.7-fold
heavier (P≤0.001; Fig. 1-a) and 8-fold fatter (P≤0.001;
Fig. 1-b) than LG during juvenile development (1-11
wk). The greatest difference in BW and abdominal fat
weight (%BW) was observed at 7 wk. where there were
large differences (3.2- and 19.6-fold, respectively)
between genetic lines (Fig. 1-c).
Microarray and RNA-Seq analyses of abdominal fat gene
expression

Differentially-expressed (DE) genes were defined as
those having a significant adjusted P-value and false
discovery rate (FDR≤0.05). Statistical analysis of the
time-course microarray study provided significant
gene sets from three contrasts: the main effect of
genotype (312) DE genes) or age (2918 DE genes),
and the interaction between genotype and age (718
DE genes). These annotated DE gene sets from the
time-course microarray study are presented as HG/
LG expression ratios in Additional file 3. These DE
gene sets were used as input files for IPA and functionally annotated as “Analysis Ready” (AR) DE genes
according to the Ingenuity Knowledge Base, which is
largely based on annotations accrued from the human
and murine biomedical literature.
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RNA sequencing of abdominal fat at 7 wk. yielded
65.8 million (M) paired-end (101 bp) reads in HG
cockerels and 66.6 M paired-end reads in the LG
(Table 1). The percentage of reads mapped to chicken
transcripts was 80.7% for the HG and 82.6% for the
LG birds. A power analysis (Additional file 4) was
conducted on the RNA-Seq dataset, using the webbased software program “Scotty” [49, 50], to demonstrate sufficient biological sample size and sequencing
depth for detection of DE genes. Power was calculated using the average of 50 M reads per sample at
three levels of fold-change (≥1.5-, 2-, or 3-fold
change) between HG and LG chickens at a significance of P≤0.05. The “Scotty” program also provided
a hierarchical cluster analysis using the Spearman
correlation as the distance metric to demonstrate
relatedness among the eight individual (4 HG and 4
LG) birds used for RNA-Seq analysis of abdominal fat
at 7 wk. The 4 HG and 4 LG abdominal fat samples
are tightly clustered according to their genotype.
Statistical analysis of the RNA-Seq dataset identified
2410 DE (FDR ≤ 0.05) genes in abdominal fat of HG
versus LG (HG/LG log2 expression ratio) chickens at
7 wk. (Additional file 5).
From the time-course microarray analysis, IPA annotated 329 “Analysis Ready” (AR)-DE genes from the
main effect of genotype, 559 AR-DE genes from the
interaction of genotype x age, and 647 AR-DE genes
in a non-redundant dataset combined from the main
effect of genotype and genotype x age interaction
(Fig. 2-a). The second Venn diagram (Fig. 2-b) presents unique and commonly shared AR-DE genes
from the time-course microarray study (genotype and
age x genotype interaction) and 2026 AR-DE genes
from RNA-Seq analysis of abdominal fat in HG and
LG chickens at 7 wk. The number of DE genes considered by IPA as “Analysis Ready” (AR-DE) is shown
in parenthesis.The Venn diagram (Fig. 2-a) presents
unique and commonly shared DE gene sets found in
HG and LG abdominal fat from the time-course
microarray study. Only “Analysis Ready” (AR) gene
sets, annotated with the Ingenuity Knowledge Base,
are represented in the Venn diagram. An additional
non-redundant gene set (combined-unique, 647 DE
genes) was assembled by combining the genotype
(329 DE genes) and age x genotype (559 DE genes)
data sets and removing duplicated genes (cDNAs)
printed on the microarray. A fourth dataset of 492
commonly-shared DE genes, found in these intersects,
was also used for Ingenuity® Pathway Analysis (IPA).
This commonly-shared DE gene dataset seems highly
enriched with genes controlling the divergence in
growth and abdominal fatness traits in HG and LG
cockerels.
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Fig. 1 Phenotypic measurements of juvenile HG and LG chickens. Average body weight (a) of HG (blue squares) and LG (red triangles) cockerels
at six ages (1-11 wk). Each symbol represents the mean ± SE of 8 individual chickens from each genotype. Average abdominal fat content (b)
(% bodyweight, %BW) of 8 individual birds from the HG and LG chickens; four chickens per age and genotype were randomly selected for
transcriptional analyses. Significant differences between genotypes at each age were determined using a one-way analysis of variance (ANOVA)
and Tukey’s multiple comparisons procedure at a significance level of P≤0.01 (**) or P≤0.001 (***). Fold differences between genotypes (HG/LG) in body
weight (kg) and abdominal fat (%BW) from 1 to 11 wk. (c). The maximum divergence in body weight and abdominal fatness occurs at 7 wk., which
was the age selected for deeper RNA-Seq analysis

The RNA-Seq analysis (Fig. 2-b) of abdominal fat from
the same 4 HG and 4 LG birds at 7 wk. provided 2026
DE genes that were annotated by IPA as “Analysis
Ready” (AR). The intersection of the genotype and age x
genotype datasets from the microarray study shows 126
commonly shared AR-DE genes. The RNA-Seq AR-DE
gene set shared 86 common genes with the main effect
of genotype AR-DE genes, and another 130 genes in
common with the age x genotype AR-DE gene set. Only
47 AR-DE genes were shared among all three DE gene
sets, derived from microarray and RNA-Seq analyses.

IPA of gene interaction networks and functional
pathways
Time-course microarray data analysis of abdominal fat in
HG and LG cockerels (1-11 wk)

Significant gene (FDR≤0.05) lists from the microarray
analysis were first annotated using the GeneBase tool on
our laboratory website [41], which provides protein IDs
(from GenBank or Swiss-Prot) derived from BLASTX/
BLASTN analysis of 18,240 cDNA probes printed on the
Del-Mar 14 K chicken array. Annotated microarray data
files (Fig. 2-a), containing the Ensembl protein ID and

Table 1 Summary of reads mapped from RNA-Seq analysis of HG and LG abdominal fat (7 wk)
HG

LG

Bird ID

Paired-End Reads

Reads Mapped (%)

Reads Unmapped (%)

Genes (FPKM > 0.5)

1536

64,372,528

58,450,255 (91%)

5,922,272 (9%)

14,171

1572

72,993,942

54,526,474 (75%)

18,467,467 (25%)

14,086

1759

72,258,015

54,988,349 (76%)

17,269,665 (24%)

14,121

1807

53,773,174

44,524,188 (83%)

9,248,985 (17%)

14,251

1890

51,157,100

42,460,393 (83%)

8,696,707 (17%)

14,241

1923

71,021,405

58,450,616 (82%)

12,570,788 (18%)

14,449

5629

75,046,371

62,063,348 (83%)

12,983,022 (17%)

14,465

5678

69,207,601

57,027063 (82%)

12,180,537 (18%)

14,362

Two replicate lanes of 8 multiplexed HG and LG abdominal fat samples were paired-end (101 bp) sequenced in an Illumina HiSeq 2000 sequencer. The percentage
of mapped and unmapped reads is shown in parenthesis. The threshold for gene detection was set at greater than 0.5 fragments per kilobase of exon per million
fragments mapped (FPKM > 0.5). Differential (DE) expression of a gene was determined by statistical difference after adjustment for a false discovery rate of
FDR ≤ 0.05. The DE genes used for Ingenuity Pathways Analysis were considered analysis ready (AR) if annotated according to the Ingenuity Knowledge Base,
accrued from human and murine models in the biomedical literature
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(329 AR-DE genes)

126

117

303

47
39

83

1857
RNA-Seq (7 wk)
HG-LG AbFat
(2026 AR-DE genes)

Fig. 2 Venn diagram of “Analysis Ready” (AR) and differentially-expressed
(DE) gene sets from the time-course (1-11 wk) microarray analysis (a) and
RNA-seq analysis (b) of abdominal fat in HG and LG cockerels (7 wk).
Three statistical contrasts were made for the microarray analysis: the main
effect (FDR ≤ 0.05) of genotype (HG vs. LG) across 6 ages (1-11 wk), age x
genotype interaction and the main effect of age. An additional non-redundant gene set (combined-unique, 647 AR-DE genes), used for
Ingenuity® Pathway Analysis (IPA), was assembled by combining the
genotype (329 AR-DE genes) and age x genotype (559 AR-DE genes)
datasets, then removing and duplicate genes (cDNAs) printed on the
14 K Del-Mar chicken microarray. The Venn diagrams represent the
number of AR-DE genes annotated in the Ingenuity® Knowledge Base.
The common genes shown in intersects were also combined and used
for IPA. The RNA-seq analysis provided 2026 AR-DE genes (FDR ≤ 0.05),
which were used for IPA and comparison with time-course microarray
datasets (b)

log2 fold-difference for each gene, were submitted for
Ingenuity® Pathway Analysis [44]. IPA provides functional annotation from the Ingenuity Knowledge Base
[indicated as “Analysis Ready” (AR)], mapping to canonical metabolic/regulatory pathways, gene interaction networks and Ingenuity® Upstream Regulator Analysis,
which provides transcription factor interaction networks
and predicted interactions between transcription factors
and their target genes.
A summary of the IPA of the time-course (1-11 wk)
microarray dataset of 647 unique AR-DE genes condensed

from the main effect of genotype and interaction of genotype x age datasets is presented in Table 2. The top five canonical pathways identified by microarray analysis were
“Oxidative Phosphorylation” (19 AR-DE genes; Additional
file 6), “Mitochondrial Dysfunction” (22 AR-DE genes),
“Eukaryotic translation initiation factor (EIF2) Signaling”
(21 AR-DE genes), “NRF2-mediated Oxidative Stress Response” (19 AR-DE genes), and “Phagosome Maturation”
(13 AR-DE genes). The top five “Upstream Regulators”
were TP53 (105 direct target genes), PPARA (50 direct
targets), MYC (78 direct targets), PPARG (45 direct targets), and MYCN (32 direct targets). Ingenuity Upstream
Regulator Analysis identified 22 DE transcription factors
from the time-course microarray study; 8 transcription
factors were up-regulated in the HG cockerels, whereas
14 upstream regulators were more abundant in LG abdominal fat. The top five “Molecular and Cellular Functions” identified by IPA from the microarray DE gene set
included “Cellular Growth and Proliferation” (285 AR-DE
genes, “Cellular Movement” (171 AR-DE genes), “Lipid
Metabolism” (129 AR-DE genes), “Molecular Transport”
(176 AR-DE genes), and “Small Molecule Biochemistry”
(163 AR-DE genes). The top five IPA categories related to
“Physiological System Development and Function” were
“Cardiovascular System” (107 AR-DE genes), “Organismal
Development” (181 AR-DE genes), “Organismal Survival”
(175 AR-DE genes), “Hematological System” (123 AR-DE
genes), and “Immune Cell Trafficking” (72 AR-DE genes).
The top 10 up-regulated genes and down-regulated
genes in abdominal fat of juvenile HG and LG chickens (1-11 wk) are also presented in Table 2.
Annotated lists of AR-DE genes are provided in
eight worksheets of Additional file 6, which show top
canonical
pathways
and
biological
functions
[“Upstream Regulators (22 AR-DE genes), Oxidative
Phosphorylation (19 AR-DE genes), LXR-RXR
Activation (9 AR-DE genes), Fatty Acid Metabolism
(61 AR-DE genes), Adipogenesis (12 AR-DE genes),
Insulin Resistance (27 AR-DE genes), VEGF Signaling
(8 AR-DE genes), and Protein Metabolism” (44 AR-DE
genes)] revealed by time-course microarray analysis. Fourteen of the 22 AR-DE transcription factors identified by
microarray analysis are expressed higher in abdominal fat
of the LG cockerels (1-11 wk). Likewise, 15 of the 19 ARDE genes involved in oxidative phosphorylation are more
abundant in the LG. Of the nine AR-DE genes belonging
to the LXR-RXR pathway, only three genes encoding
transport proteins (TF, APOA1 and ALB) are up-regulated
in visceral fat of the LG birds.
Gene interaction networks identified from the time-course
microarray analysis (1-11 wk)

A top gene interaction network (Fig. 3-a), identified by
IPA as “Lipid Metabolism”, shows interaction of two
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Table 2 IPA summary of microarray analysis of abdominal fat in HG and LG cockerels (1-11 wk)
Top Canonical Pathways

p-value

Overlap

Ratio

Oxidative Phosphorylation

7.88E-10

17.4%

19/109

Mitochondrial Dysfunction

1.37E-08

12.9%

22/171

EIF2 Signaling

2.33E-07

11.4%

21/185

NRF2-mediated Oxidative Stress Response

2.84E-06

10.6%

19/180

Phagosome maturation

7.93E-05

10.8%

13/120

Top Upstream Regulators

p-value of overlap

# Target genes

TP53

2.92E-21

105

PPARA

1.46E-18

50

MYC

2.75E-16

78

PPARG

1.94E-14

45

MYCN

2.51E-13

32

p-value

# Genes

Cellular Growth and Proliferation

1.96E-04 - 1.11E-16

285

Cellular Movement

2.13E-04 - 3.09E-14

171

Lipid Metabolism

2.79E-04 - 7.14E-13

129

Molecular Transport

2.72E-04 - 7.14E-13

176

Small Molecule Biochemistry

2.79E-04 - 7.14E-13

163

p-value

# Genes

Top Molecular and Cellular Functions

Physiological System Development and Function
Cardiovascular System

2.58E-04 - 7.81E-12

107

Organismal Development

2.58E-04 - 7.81E-12

181

Organismal Survival

4.90E-05 - 3.31E-10

175

Hematological System

2.72E-04 - 3.05E-08

123

Immune Cell Trafficking

2.72E-04 - 3.05E-08

Top Up-regulated genes

HG/LG Ratio

72
Top Down-regulated genes

HG/LG Ratio

FN1

12.58

TGM2

−5.86

SCD

10.69

MED27

−5.06

PPP1R9A

9.23

SESTD1

−4.07

XYLT2

5.14

ALB

−3.80

PIGC

4.52

RPL18A

−3.78

NFASC

4.02

MT-ND1

−3.21

PLEC

3.55

HSD11B1

−3.11

ABHD3

3.40

BM2

−3.00

FASN

3.34

TAGLN

−2.95

ARID4B

3.30

ANGPTL3

−2.94

Ingenuity Pathway Analysis (IPA) was used for functional annotation and mapping of 647 DE genes from the time-course microarray analysis of abdominal fat in
HG and LG cockerels (1-11 wk) that were “Analysis Ready” (AR-DE). This unique (non-redundant) gene set was compiled from AR-DE genes found in the main
effect of genotype or the genotype x age interaction

opposing transcription factors [peroxisome proliferatoractivated receptor gamma (PPARG) and peroxisome
proliferator-activated receptor delta (PPARD)] with their
respective direct target genes. Six direct targets of the
PPARG are metabolic enzymes up-regulated in abdominal
fat of the HG chickens [stearoyl-CoA desaturase (delta-9desaturase; SCD); diacylglycerol O-acyltransferase 2
(DGAT2), acyl-CoA synthetase long-chain family member
1 (ACSL1), (ATPase, H+-transporting, lysosomal 34 kDa,

V1 subunit D (ATP6V1D), collagen alpha 1 (COL1A1),
and thrombospondin receptor (CD36)]. The expression of
several other genes were downregulated in the HG cockerels (or expressed higher in LG) [PPARD, ALDH9A1,
monoglyceride lipase (MGLL), oxidation resistance 1
(OXR1), and pyruvate dehydrogenase kinase, isozyme 4
(PDK4)]. The adipocyte enhancer binding protein 1
(AEBP1), which was expressed higher in abdominal fat of
LG birds, directly affects both PPARG and CD36. On the
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a

Higher expression in HG
Higher expression in LG

b

Fig. 3 Interactions of two transcription factors (PPARG and PPARD) and their direct target genes that control lipid metabolism in abdominal fat of juvenile
HG and LG chickens. This gene interaction network (a) was identified by microarray analysis and Ingenuity® Pathway Analysis (IPA) from a combined
unique list (647 AR-DE genes) merged from DE genes in the main effect of genotype (averaged across 6 ages) with DE genes from the interaction of age
and genotype (see Fig. 2). Red gene symbols indicate higher expression in abdominal fat of HG birds, while green gene symbols indicate higher expression
in the LG. Ingenuity® Upstream Regulator Analysis identified direct target genes (b) of two opposing ligand-activated transcription factors (PPARG and
PPARD). IPA predicts the activation of PPARG (orange symbol and arrows) and inhibition of PPARD (blue symbols and arrows), based on the observed
expression of DE genes and the expected mammalian responses found in the Ingenuity Knowledge Base

other hand, PPARD and many of its direct target genes
(10 AR-DE genes) are up-regulated in the slower-growing
and leaner LG genotype, with the exception of two genes
(SCD and CD36), which were highly expressed in the HG.
The two opposing transcription factors (PPARG and
PPARD) also share several down-regulated target genes in
the HG, including PDK4, ALDH9A1, ACSL, SLC27A1 and

VLDLR. The potent LPL inhibitor, angiopoietin-like 3
(ANGPTL3), solute carrier family 22 (organic cation transporter), member 3 (SLC22A3), glutamate-ammonia ligase
(GLUL), and thrombospondin 1 (THBS1), like PPARD, are
up-regulated in abdominal fat of LG cockerels. Additional
genes with higher expression in the LG include plasminogen (PLG), several ATPases, heat shock 60 kDa protein 1
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or chaperonin (HSPD1) and hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1), which degrades glucocorticoid,
interact with direct targets of PPARD (i.e., VLDLR, THBS1
and CD36), whereas, THBS2 and collagen type VI were
up-regulated in visceral fat of the HG chickens. Interestingly, an equal number of unique ATPases were associated
with either PPARG in the HG or PPARD in the LG
chickens.
Numerous direct targets of PPARG were identified by
Ingenuity Upstream Regulator Analysis from DE genes
identified by the time-course (1-11 wk) microarray study
of abdominal fat of HG and LG chickens (Fig. 3-b).
Twenty-seven direct DE genes of PPARG were expressed
at higher levels in abdominal fat of the HG chickens,
whereas 13 direct gene targets were more abundant in
the LG chickens. This detailed view of PPARG target
genes predicts (based on literature accrued in the
Ingenuity Knowledge Base and observed expression
values) that PPARG up-regulates or activates 31 direct
gene targets (orange arrows) in the HG chickens.
Among these up-regulated genes, most control lipogenesis, adiposity and energy metabolism (SCD, FASN, FN1,
DGAT2, CEBPA, LPL, FABP4, INSIG2, IRS1, PCK1,
SCD, SOD1, SERPINA1, and ACSL1). Whereas, PPARD
expression was higher in the LG chickens and predicted
to be inhibited (blue color arrows) and downregulated in
the HG chickens (or higher in the LG), which agrees
with our observed expression values (Fig. 3-b). Eight
down-regulated genes (PDK4, PLP1, SIRT5, SLC22A3,
THBS1, VLDLR, ALDH9A1, ANGPTL3, and CSAD) were
predicted to be inhibited by PPARD (indicated by the
blue arrows) in visceral fat of the HG; these genes were actually expressed higher in the slow-growing LG chickens
as indicated by the green-colored gene symbols.
Another gene interaction network controlling lipid
metabolism (Fig. 4-a), centered on the up-regulated
transcription factor CCAAT/enhancer binding protein,
alpha (CEBPA), was found in a subset of 252 commonly shared genes from the microarray analysis (see
Fig. 2-a). CEBPA directly interacts with seven up-regulated genes in HG birds [argininosuccinate synthase
1 (ASS1), acyl-CoA synthetase long-chain family
member 1 (ACSL1), DGAT2, FABP4, Kruppel-like factor 2 (KLF2), E2F transcription factor 4 (E2F4), and
ADP-ribosylation factor-like 6 interacting protein 5
(ARL6IP5)]. Four direct targets of CEBPA were downregulated in HG abdominal fat including F-box and
WD repeat domain containing 7, E3 ubiquitin protein
ligase (FBXW7), Kruppel-like factor 5 (KLF5), guanylate binding protein 1, interferon-inducible (GBP1),
and mRNA turnover 4 homolog, S. cerevisiae
(MRTO4). Ubiquitin ligase (FBXW7) has direct interactions with DGAT2, FABP4, KLF2, KLF5, ADPribosylation factor-like 6 interacting protein 1
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(ARL6IP1), DEP domain containing MTOR-interacting
protein (DEPTOR) and mediator complex subunit 27
(MED27). Other members of this lipogenic network
include exostosin glycosyltransferase 2 (EXT2),
hemoglobin, epsilon 1 (HBE1), Kruppel-like factor 13
(KLF13), carbonic anhydrase IX (CA9), inhibitor of
DNA binding 3 (ID3), dolichyl-phosphate betaglucosyltransferase (ALG5), annexin A5 (ANXA5),
farnesyl-diphosphate farnesyltransferase 1 (FDFT1)
and acyl-CoA synthetase family member 2 (ACSF2).
Ingenuity Upstream Regulator Analysis identified 18
AR-DE genes as direct targets of CEPBA (Fig. 4-b), 13
lipogenic AR-DE genes were up-regulated in the HG
genotype (FASN, DAGT2, LPL, CEBPA, FABP4 and
IRS2). Whereas, only five AR-DE genes were downregulated in the HG birds (ALB, KLF5, HSD11B1, HLA-B,
and GBP1) in the subset of 252 commonly-shared genes
from microarray contrasts (see Fig. 2-a). The Ingenuity
Upstream Regulator Analysis predicts that CEBPA was
activated in the HG chickens and led to activation of
eight genes (orange arrows) or inhibition (blue blunted
line) of a single gene, major histocompatibility complex,
class I, B (HLA-B). Based on our observed expression
values and expected responses from the mammalianbased Ingenuity Knowledge Base, the Upstream Analysis
predicts that KLF2 would be inhibited (blue gene
symbol), while clearly its expression was more abundant
in HG abdominal fat. KLF2 was predicted to inhibit
three major genes (CEBPA, FABP4, and MYH10), highly
expressed in the HG, and would further inhibit the
embryonic form of hemoglobin, epsilon 1 (HBE1). The
yellow arrows point to a contradiction between information accrued in the Ingenuity Knowledge Base and the
expected state (inhibited, blue) of two target DE genes
[thrombospondin receptor (CD36) and ASS1], although
their actual state was upregulated (activated, red
symbol). There is predicted uncertainty (grey arrows)
about KLF2 inhibition of ID3 (blunted-yellow line),
which is down regulated in the HG. Ingenuity correctly
predicts FBXW7 to be inhibited (blue symbol), since it
was expressed lower in HG, and that this ubiquitin protein ligase would directly block up-regulation of three
ligogenic genes (CD36, DGAT2 and FABP4) (blunt orange line), along with uncertainty about the ability of
FBXW7 to block (blunt yellow line) the down-regulated
KLF5 (green symbol). It is clear from these observations
that CEBPA is major lipogenic transcription factor and a
major contributor to the higher growth and greater fat
accretion found in the HG cockerels.
RNA-Seq analyses of abdominal fat in four HG and four LG
chickens at 7 wk

RNA-Seq analysis revealed 2410 DE (FDR≤0.05;
FPKM > 0.5) genes at 7 wk. (Additional file 5), which was
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a

Higher expression in HG
Higher expression in LG

b

Fig. 4 This adipogenic gene network is centered on the up-regulated transcription factor CEBPA and interactions with several other transcription
regulators (a). Another major gene interaction network identified by a time-course microarray analysis of abdominal fat of HG and LG chickens
(1-11 wk). Ingenuity Pathway Analysis (IPA) identified this functional gene interaction network from the unique set of 647 AR-DE genes shown in
the Venn diagram (Fig. 2a). Red gene symbols indicate higher expression in HG adipose tissue, while green gene symbols indicate higher
expression in visceral fat of the LG. The Ingenuity® Upstream Regulator Analysis determined additional direct target genes of CEBPA, KLF2 and
FBXW7 (b). Ingenuity predicts the activation of CEPBA (orange gene symbol and arrows) and inhibition of KLF2 and FBXW7 (blue symbol and arrow)

the age of greatest extremes in growth and fatness phenotypes exhibited by HG and LG cockerels. IPA identified
2026 DE genes from the RNA-Seq dataset as annotated
and “Analysis Ready” (AR) from the RNA-Seq dataset. A
summary of the IPA of this RNA-Seq dataset is presented
in Table 3. The top five canonical pathways populated by
DE genes from the RNA-Seq analysis were “Axonal Guidance Signaling, Acute Phase Response Signaling, Role of
Tissue Factor in Cancer, Coagulation System and Complement System” (see Additional file 7 for detailed gene lists).
The top five “Upstream Regulators” predicted by Ingenuity Upstream Analysis were ESR1 (234 AR-DE targets),
TP53 (230 AR-DE targets), CTNNB1 (132 AR-DE targets), ESR2 (83 AR-DE targets), and SMARCA4 (105 ARDE targets). The top “Molecular and Cellular Functions”

over-represented by DE genes from the RNA-Seq analysis
were “Cellular Movement” (538 AR-DE genes), “Cellular
Growth and Proliferation” (866 AR-DE genes), “Cellular
Morphology” (606 AR-DE genes), “Cell Death and Survival” (706 AR-DE genes), and “Cellular Assembly and
Organization” (452 AR-DE genes). The top “Physiological
System Development and Function” categories represented by RNA-Seq DE genes were “Organismal Development” (701 AR-DE genes), “Tissue Development” (801
AR-DE), “Cardiovascular System” (373 AR-DE genes),
“Embryonic Development” (476 AR-DE genes) and “Organismal Survival” (530 AR-DE genes). The top ten upregulated genes in HG abdominal fat included SCD,
whereas the top ten up-regulated genes in the LG cockerels mainly encode hemostasis (FGA, FGB, FGG, PLG
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Table 3 IPA summary of RNA-Seq analysis of abdominal fat in HG and LG cockerels (7 wk)
Top Canonical Pathways

p-value

Overlap

Ratio

Axonal Guidance Signaling

1.07E-11

20.3%

88/434

Acute Phase Response Signaling

4.80E-11

27.2%

46/169

Role of Tissue Factor in Cancer

4.05E-10

30.9%

34/110

Coagulation System

4.13E-09

48.6%

17/35

1.20E-08

45.9%

Complement System
Top Upstream Regulators

p-value of overlap

17/37
#Target Genes

ESR1

6.70E-29

234

TP53

1.48E-24

230

CTNNB1

4.21E-19

132

ESR2

1.14E-17

83

SMARCA4
Top Molecular and Cellular Functions

3.03E-13

105

p-value

# Genes

Cellular Movement

7.08E-08 – 5.98E-43

538

Cellular Growth and Proliferation

7.49E-08 - 3.56E-37

866

Cell Morphology

1.37E-07 - 5.49E-35

606

Cell Death and Survival

1.31E-07 - 2.52E-30

706

Cellular Assembly and Organization

3.03E-08 - 2.15E-29

452

Physiological System Development and Function

p-value

# Genes

Organismal Development

1.40E-07 - 1.18E-29

701

Tissue Development

1.53E-07 - 9.90E-28

801

Cardiovascular System

1.47E-07 - 5.03E-27

373

Embryonic Development

5.07E-08 – 7.56E-25

476

Organismal Survival

8.82E-09 - 1.54E-24

Top Up-regulated Genes

530

Log2 Ratio

Top Down-regulated Genes

Log2 Ratio

MYL1

7.55

GC

−8.52

SCD

7.02

FGB

−8.34

ACTN2

6.15

PLG

−8.23

CASQ2

5.91

AHSG

−8.18

TNNC2

5.72

FGA

−8.14

MYH3

5.58

HRG

−7.73

RIPPLY3

5.03

FGG

−7.62

TNNI2

4.44

ALB

−7.40

SMOC1

4.13

APOH

−6.93

ABHD3

4.08

KNG1

−6.63

Ingenuity Pathway Analysis (IPA) was used for functional annotation and mapping of 2026 “Analysis Ready” DE genes identified by RNA-Seq analysis of abdominal
fat in four HG and four LG cockerels at 7 wk. These tissue samples were from the same HG and LG birds used for microarray analysis at this age

and KNG1) and transport or binding (ALB, GC, APOH
and FABP1) proteins.
Additional functional categories and canonical pathways
represented by AR-DE genes from the RNA-Seq analysis
(Additional file 7) include “Upstream Regulators (58 genes),
Acute Phase Signaling (48 genes, Coagulation System (17
genes), Intrinsic Prothrombin Activation (12 genes),
Extrinsic Prothrombin Activation (11 genes), LXR/RXR Activation (31 genes), Fatty Acid Metabolism (158 genes),

Adipogenesis Pathway (26 genes), Insulin Resistance (71
genes), VEGF Signaling (18 genes), and Protein
Metabolism” (63 genes). Ingenuity Analysis recognized 58
AR-DE genes as “Upstream Regulators”, where 24 AR-DE
transcription factors were expressed higher in HG
abdominal fat and 34 AR-DE upstream regulators were upregulated in the LG. The “Acute Phase Signaling Pathway”
was also overpopulated by 40 AR-DE genes that were upregulated in the LG, whereas, only 8 genes in this pathway
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were expressed in abdominal fat of the HG. Likewise, only
a single up-regulated gene in the HG was assigned to the
canonical “Coagulation System” (PLAU) and “Intrinsic
Prothrombin Activation Pathway” (COL18A1), while 11
AR-DE genes belonging to the “Extrinsic Prothrombin
Activation Pathway” were all over-expressed in the LG.
Similarly, the “LXR-RXR Activation Pathway” was composed of 23 AR-DE genes highly expressed in LG visceral
fat compared to only 8 up-regulated genes from the HG
birds. A total of 158 AR-DE genes were assigned by IPA to
“Fatty Acid Metabolism” and of these 84 AR-DE genes were
up-regulated in the LG cockerels compared to 76 genes
expressed high in the HG. Another critical canonical
pathway identified was “Adipogenesis”, which was populated by 15 up-regulated AR-DE genes in the LG and 11
up-regulated genes in the HG cockerels. Insulin resistance
is another important biological process related to visceral
fatness and endocrine signaling, where 41 AR-DE genes
were expressed higher in the LG chickens and 30 genes
were more abundant in the HG. The vascular endothelial
growth factor (VEGF) signaling pathway was dominated by
13 up-regulated AR-DE genes in the HG birds, with only 5
genes up-regulated in the LG. In contrast, protein metabolism had an equal number of AR-DE genes from HG (31
up-regulated genes) and LG (32 up-regulated genes)
cockerels at 7 wk.
Gene interaction networks revealed from RNA-Seq analysis
of HG and LG abdominal fat

From 2410 DE genes identified by RNA-Seq analysis of
abdominal fat in HG and LG cockerels at 7 wk, a total of
2026 DE genes were determined by IPA as “Analysis
Ready” (AR) and subjected to an IPA “Core Analysis”.
Two gene interaction networks were highly populated by
several hemostasis genes that were highly expressed in
abdominal fat of the LG chickens at 7 wk (Fig. 5). Panel A
shows a gene interaction network functionally annotated
by IPA as “Cell-to-Cell Signaling, Hematological System
Development and Function”. This network was composed
of several DE genes involved in acute phase signaling and
blood coagulation (see Additional file 7). These genes
included fibrinogen A, B and G (FGA, FGB and FGG),
molecular transporters [albumen (ALB), transthyretin
(TTR), apolipoprotein A-I (APOA1), apolipoprotein H
(APOH), transferrin (TF), group-specific component (GC;
Vitamin D binding protein), solute carrier family 9, subfamily A (SLC9A8), serpin peptidase inhibitor, clade F,
member 2 (SERPINF2), and alpha-2-Heremans-Schmidglycoprotein (AHSG or fetuin-A). Other genes expressed
higher in visceral fat of the LG chickens include lecithincholesterol acyltransferase (LCAT), complement component 3 (C3), transglutaminase 2 and 4 (TGM2 and
TGM4), mal or T-cell differentiation protein (MAL), cyclin L2 (CCNL2), and AT rich interactive domain 5A
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(ARID5A). Other genes expressed higher in the HG
chickens were dermatopontin (DPT), thrombospondin 2
(THBS2), serpin peptidase inhibitor, clade F, member 1
(SERPINF1), which is a neurotrophic factor and potent
inhibitor of angiogenesis, phospholipid transfer protein
(PLTP), integrin, alpha V (ITGAV), and lectin, galactosidebinding, soluble, 8 (LGALS8).
The other hemostatic gene network revealed by RNASeq analysis (Fig. 5-b) was composed of several coagulation
factors (F2, F3, F5, F8, F10, SERPINB2, and FGB), which
were all over-expressed in abdominal fat of LG cockerels.
The complement component (C1S), calreticulin (CALR),
the anion exchanger SLC4A1, kinesin family member 7
(KIF7), carbonic anhydrase II (CA2) and regulator of
G-protein signaling 19 (RGS19) were also expressed higher
in the LG. Several additional genes in this direct interaction
network were up-regulated in the HG, including mitogenactivated protein kinase 1 (MAPK1), parvin alpha (PARVA),
the monocarboxylate transporter SCL16A7, coiled-coil
domain containing 2 (GCC2), CDC42 binding protein
kinase alpha (CDC42BPA), LDL receptor related protein 6
(LRP6), frizzled-related protein (FRZB), wingless-type
MMTV integration site family member 16 (WNT16), protein kinase C and casein kinase substrate in neurons 3
(PACSIN3), fibrinogen-like 2 (FGL2) and mitochondrial fission regulator 1 (MTFR1). This gene interaction network
was functionally annotated by IPA as “Hematological
Disease”.
Sixteen of the 17 DE genes were over expressed in the
IPA canonical coagulation system, which includes the
extrinsic and intrinsic prothrombin activation pathways
(Fig. 6; Additional file 7). The up-regulated hemostasis
genes found in the LG chickens include six coagulation
factors (F2, F3, F5, F8, F10 and F13B), three fibrinogen
subunits (FGA, FGB and FGG), two serpin peptidase inhibitors (SERPINC1 and SERPINF2), plasminogen (PLG), kininogen 1 (KNG1), bradykinin (BDK), protein C (PROC),
and von Willebrand factor, C and EGF domains (VWCE).
In contrast, plasminogen activator, urokinase (PLAU) was
the only coagulation-related gene that was expressed
higher in HG abdominal fat. Clearly, the diminished abdominal fat mass of slower-growing LG cockerels reflects a
highly prothrombotic state; although the consequence on
endocrine signaling and/or lipid metabolism remains unknown. However, microarray analysis of liver in the HG
and LG cockerels does show higher expression of four coagulation genes (FGA, FGB, SERPINF2, and KNG1) in the
LG birds (Cogburn, LA unpublished data). Presently, we
do not know if local activation of the coagulation system in
adipose tissue (or liver) affects the systemic hemostatic
mechanism, which normally would rely on availability of
coagulation precursors synthetized mainly in the liver.
One metabolic gene network, annotated by IPA as
“Lipid Metabolism, Small Molecule Biochemistry and
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a

b

Higher expression in HG
Higher expression in LG

Fig. 5 RNA-Seq analysis of abdominal fat at 7 wk identified two gene interaction networks controlling fibrinogenesis and hemostasis that are populated
by genes highly expressed in LG cockerels. Panel a shows an interaction network functionally annotated by IPA as “Cell-to-Cell Signaling, Hematological
System Development and Function”. The second panel (b) shows a gene network, annotated by IPA as “Hematological Disease”, which involves
interaction of a large cluster of clotting factors with multiple cell signaling components

Energy Production”, was centered on interactions of two
transcription factors (SREBF1 and SREBF2) and their
numerous activated target genes, most of which were
highly expressed in abdominal fat of the faster-growing
and fatter HG cockerels at 7 wk (Fig. 7-a). The two
highest-expressed genes found in this lipogeneic network
were SCD (10.7-fold higher) and 24-dehydrocholesterol
reductase (DHCR24) [5.5-fold higher], the final enzyme
in cholesterol biosynthesis. Other up-regulated genes in
visceral fat of HG chickens were diacylglycerol O-acyltransferase 2 (DGAT2), lipin 1 (LPIN1), insulin induced
gene 1 (INSIG1), ACACA, FADS1, SQLE, SC5D, LSS,
FADS2, CYB5A, SLC38A6, MSMO1, KLF13 and glycophorin C (GYPC). Only seven genes in this network
were expressed higher in abdominal fat of the LG

cockerels [AGTR1, ATP12A, PPARG coactivator 1 beta
(PPARGC1B), ACACB, salt inducible kinase 1 (SIK1),
HMG CoA synthase (HMGCS) and solute carrier family
4 member 4 (SLC4A4).
Ingenuity® Upstream Regulator Analysis identified 36
AR-DE genes that are direct targets of SREBF1 (22 genes
were expressed higher in the HG, which is consistent
with activated SREBF1) and 16 AR-DE genes that are
direct targets of SREBF2 (12 genes were expressed
higher in the HG, which is consistent with activation of
SREBF2) (Fig. 7-b). As direct targets of SREBF1, the four
most abundant genes in abdominal fat of the HG were
myosin light chain 1 (MYL1), SCD, troponin I type 2,
skeletal, fast (TNNI2) and FADS2, whereas MAT1A,
APOA5, TF and ADH1C were the highest-expressed
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Intrinsic Pathway

Extrinsic Pathway

Higher Expression in LG AbFAT
Higher Expression in HG AbFAT
Fig. 6 Ingenuity Pathway Analysis of RNA-Seq data showed that the canonical coagulation system was over-represented by up-regulated genes
in abdominal fat of LG cockerels. Plasminogen activator, urokinase (UPA) was the only coagulation gene expressed higher in visceral fat of the HG
birds. The IPA indicates that 16 out of 17 DE genes are expressed at higher levels in the LG birds, while only plasmogenin activator, urokinase
was up-regulated in abdominal fat of HG cockerels. Both the intrinsic (12 AR-DE genes) and extrinsic (11 AR-DE genes) pathways in visceral fat of
LG birds are highly-populated by up-regulated coagulation genes (see Additional file 7 for functional AR-DE gene lists)

target genes of SREBF1 found in the LG at 7 wk. The
Ingenuity Upstream Analysis predicts that both SREBF1
and SREBF2 are activated (orange gene symbols) and
that 19 DE target genes would be activated (orange
arrows). Twelve of these highly-expressed genes are
activated by both transcription factors (ACSL1, CYB5A,
DHCR7, FADS2, FASN, INSIG1, LSS, MSMO1, PCYT1A,
SC5D, SCD and SQLE). SREBF1 appears to inhibit only
three genes [alcohol dehydrogenase 1C (class I), gamma
polypeptide (ADH1C), apolipoprotein A-V (APOA5) and
androgen receptor (AR)], which were over-expressed in
the LG chickens. Only 13 direct target genes of SREBF1
and/or SREBF2 were expressed higher in abdominal fat
of the LG chickens. Perilipin 2 (PLIN2) was the only
direct target of SREBF2 that was expressed higher in
visceral fat of the LG cockerels.
RNA-Seq analysis revealed interactions between the vitamin D receptor (VDR) and several direct targets of SREBF1
including FASN, ACACA and LPIN1, which were upregulated in the HG birds (Fig. 8-a). Other up-regulated
genes in the HG chickens include cytochrome p450 oxidoreductase (POR), multimerin 2 (MMRN2), quaking (QKI),
mercaptopyruvate sulfurtransferase (MPST), laminin

subunit alpha 2 (LAMA2), allograft inflammatory factor 1
like (AIF1L), dystonin (DST), VPS26 retromer complex
component A (VPS26A) and kinesin family member 3A
(KIF3A). Another group of 15 genes were up-regulated in
abdominal fat of the LG [APOA1, TTR, RBP7, angiotensinogen (AGT), aldo-keto reductase family 1, member B10
(AKR1B10), poly(rC) binding protein 3 (PCBP3), coenzyme
Q3, methyltransferase (COQ3), laminin subunit gamma 2
(LAMC2), collagen type VII alpha 1 (COL7A1),
hematopoietic cell-specific Lyn substrate 1 (HCLS1), 2′,3′cyclic nucleotide 3′ phosphodiesterase (CNP), prolylcarboxypeptidase (PRCP), methionine adenosyltransferase 1A
(MAT1A), prostaglandin D2 synthase (PTGDS),carnitine
palmitoyltransferase 1A (CPT1A), and solute carrier family
51 alpha subunit (SLC51A)].
Ingenuity Upstream Regulator Analysis predicts that
the expression of VDR (Fig. 8-b) would be inhibited
(blue gene symbol), which would lead to downregulation of four direct target genes [serpin peptidase
inhibitor, clade C (antithrombin), member 1 (SERPINC1), transmembrane protease, serine 2 (TMPRSS2),
ATP binding cassette subfamily C member 3 (ABCC3),
and cadherin 1 (CDH1). Of the 17 DE direct targets of
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a

b

Higher expression in HG
Higher expression in LG

Fig. 7 IPA of RNA-Seq data revealed a gene network controlled by the lipogenic transcription factors SREBF1 and SREBF2 (a). Panel b shows
additional direct gene targets that are either unique to, or shared by, SREBF1 (35 DE genes) and SREBF2 (16 DE genes). The Ingenuity® Upstream
Analysis predicates activation (orange arrows and symbols) or inhibition (blunt blue line) of direct target genes. The predicted activated (orange
arrows) or inhibited (blunt blue lines) state of DE target genes is based on the expected responses accrued in the Ingenuity Knowledge Base

the VDR, three genes [angiotensinogen converting
enzyme (ACE), myosin, heavy chain 3, skeletal muscle,
embryonic (MYH3) and phosphate regulating endopeptidase homolog, X-linked (PHEX)] were expressed at
higher levels in abdominal fat of the HG chickens. The
up-regulated expression of six genes in the LG birds
(AGT, AGTR1, F3, FGG, PNPLA2 and SELE) was inconsistent with the expected state of these genes (blunted
yellow edges) from the Ingenuity Knowledge Base.
However, the effect of the VDR was not predicted for
three AR-DE genes [the inflammatory chemokine, C-XC motif chemokine ligand 8 (CXCL8), phosphate
regulating endopeptidase homolog, X-linked (PHEX) and
perilipin 2 (PLIN2).
Another gene network functionally annotated by IPA as
controlling lipid metabolism was centered on the

androgen receptor (AR), which was expressed higher in
abdominal fat of the LG cockerels, and the interaction of
its direct target genes with three additional transcription
factors [SREBF2, PPARG coactivator 1 beta (PPARGC1B)
and MKL1/myocardin like 2 (MKL2)] (Fig. 9-a). Eight
genes are direct targets of the lipogenic transcription
factor SREBF2, where CYB5A, FADS2, DHCR7, MSMO1,
SQLE, LSS and SCD were up-regulated in HG visceral fat,
and only solute carrier family 4 member 4 (SLC4A4) was
expressed higher in the LG. Two direct targets of the AR
[methylsterol monooxygenase 1 (MSMO1) and 7dehydrocholesterol reductase (DHCR7)] are also direct
targets of SREBF2, while DHCR24 is a direct target of the
AR and PPARGC1B, both of these transcription regulators
were up-regulated in LG chickens. PPARGC1B also shares
three genes that are direct targets of SREBF2 [i.e., squalene
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a

Higher expression in HG

b

Higher expression in LG

Fig. 8 Gene network showing interactions of two ligand-activated transcription factors (VDR and SREBF1) from RNA-Seq analysis of abdominal fat
in HG and LG cockerels at 7 wk. (a). This network of 30 DE genes was functionally annotated by IPA as “Energy Production; Lipid Metabolism”.
The expression of 13 DE genes was higher in abdominal fat of HG cockerels, while 17 DE genes were more abundant in the LG. Panel b provides
16 direct targets of VDR, and VDR itself, which were largely up-regulated in LG abdominal fat at 7 wk., only three genes were expressed higher in
the HG. Upstream Regulator Analysis predicted inhibition of the VDR gene (blue symbol) and inhibition (blue arrow or blunt lines) of target genes
reflecting its up-regulation in the LG

epoxidase (SQLE), lanosterol synthase (LSS) and SCD].
Three additional targets of MKL2 are solute carrier family
35 member D3 (SLC35D3), a key regulator of dopamine
signaling, and thromboxane A synthase 1 (TXBAS1) both
of which were up-regulated in abdominal fat of the LG
cockerels, whereas calponin 2 (CNN2) is a third target
gene of MKL2, which was expressed higher in the HG
chickens. Fourteen additional genes in this network are
direct targets of the AR, where 9 genes are expressed
higher in the LG and 5 up-regulated in the HG. Among
the 9 upregulated target genes of AR found in visceral fat
of the LG line were endothelin 2 (EDN2), forkhead box P2
(FOXP2), tyrosine aminotransferase (TAT), prostate stem
cell antigen (PSCA), the sodium-coupled amino acid

transporter (SLC38A5), ELOVL fatty acid elongase 2
(ELOVL2), transmembrane protease, serine 2 (TMPRSS2),
acyl-CoA binding domain containing 7 (ACBD7) and
kinesin family member 15 (KIF15). Ingenuity Upstream
Regulator Analysis identified 85 direct targets of the AR
gene from the RNA-Seq analysis of abdominal fat in the
HG and LG cockerels at 7 wk. (Fig. 9-b). Thirty-five of the
known direct targets of the AR were upregulated in HG
cockerels, while 50 DE genes were over expressed in
visceral fat of the LG birds. The predicted inhibition of the
AR and 26 of its target genes is based on the observed
down-regulation of the AR (blue symbol and arrows) in
the HG abdominal fat (or up-regulation in LG birds as indicated by green gene symbols) from the RNA-Seq
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a

Higher expression in HG
Higher expression in LG

b

Fig. 9 RNA-Seq analysis of abdominal fat in HG and LG cockerels at 7 wk. shows a gene interaction network centered on interactions between SREBP2
and the AR (a). SREBP2 and its direct targets are expressed higher in the HG cockerels, while the AR and 8 target genes were up-regulated in the LG.
Ingenuity Upstream Analysis predicts that the AR should be activated in the HG (orange gene symbol), based on the up-regulated condition (orange
arrows and red gene symbols) of 27 target genes (b). An additional 22 DE genes, known direct targets of the AR, were up-regulated (green gene symbols)
in abdominal fat of the LG birds. Ingenuity predicted activation is indicated by orange arrows), while predicted inhibition is shown by blunted blue lines

analysis. The two highest up-regulated DE genes in the
HG among direct targets of the AR were calsequestrin 2
(CASQ2) and 24-dehydrocholesterol reductase (DHCR24),
which catalyzes the final step in cholesterol synthesis.
Another terminal enzyme of cholesterol synthesis,
DHCR7, was also upregulated in abdominal fat of the HG
cockerels. Ingenuity Upstream Analysis indicated that
three up-regulated genes in the HG cockerels [CASQ2,

nucleosome assembly protein 1 like 1 (NAP1L1), and
nerve growth factor receptor (NGFR)] would be actively
blocked (red blunted lines) by the AR. Another steroid
hormone receptor up-regulated in visceral fat of the LG
cockerels was the progesterone receptor (PGR), which also
had a large number of direct target genes (36 were upregulated in the LG and 25 DE genes were expressed higher
in the HG birds) in the RNA-Seq dataset.
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Verification of differential gene expression by
quantitative RT-PCR (qRT-PCR)

Based on biological function, candidate DE genes were selected from the microarray (1-11 wk) and RNA-Seq (7 wk)
analyses for verification of expression by qRT-PCR assay.
Three genes (ME1, DIO3, and scGH), not identified by
either microarray or RNA-Seq analysis, were also examined
by qRT-PCR analysis due to special interest. Expression patterns of four transcriptional regulators which directly regulate adipogenesis and/or lipogenesis are shown in Fig. 10-a.
Three of these transcriptional regulators [PPARG, CEBPA
and thyroid hormone responsive spot 14, alpha (THRSPA)]
show very similar patterns of expression, being up-regulated
in HG chickens. Similarly, SREBF1 was 4-fold higher in HG
chickens at 1 wk. (P ≤ 0.01), although not different at 3 and
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11 wk. Four targets of these transcriptional regulators, controlling lipogenesis, are shown in Fig. 10-b. Interestingly,
SCD was the second highest-expressed gene identified in abdominal fat of HG chickens by time-course (1-11 wk)
microarray analysis (Table 2), being over ~110- and ~90-fold
higher (P≤0.001) at 1 and 7 wk., respectively. Malic enzyme
1, NADP(+)-dependent, cytosolic (ME1) was up-regulated
in the HG at 1, 5 and 7 wk., with a peak difference at 5 wk.
(~2.5-fold increase in HG chickens). Both FASN and
DGAT2 were also significantly up-regulated in HG chickens
(P≤0.001) at 1, 7 and 9 wk., with the greatest fold-change
observed at 7 wk. (2.8- and 9.7-fold, respectively).
Transcript abundance was also examined by qRTPCR for seven genes which appear to be associated
with leanness (Fig. 11). The nuclear-hormone receptor
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Fig. 10 Verification of differentially expressed genes associated with abdominal fatness by qRT-PCR analysis. The abundance of eight genes, expressed
higher in the HG and associated with their increased fatness [4 transcription factors (a) and 4 metabolic enzymes (b)], was verified by qRT-PCR analysis.
Data points represent the mean ± SE of 4 birds/genotype and age. Significant differences between genotypes at each age were determined using a
one-way ANOVA and Tukey’s multiple comparisons procedure at a significance level of P≤0.05 (*), P≤0.01 (**) and P≤0.001 (***)
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PPARD (see Fig. 2) was up-regulated in abdominal fat
of LG chickens between 1 and 5 wk., with an 8.6-fold
difference at 1 wk. Carnitine palmitoyltransferase I
(CPT1A), which mediates the transport of long chain
fatty acids across the outer mitochondrial membrane,
was also higher in the LG during early development
(1-7 wk) with an average of a 2.4-fold increase across
these ages. Two key enzymes in ketogenesis [HMGCoA synthase 1, soluble (HMGCS1) and 3-hydroxy-3methylglutaryl-CoA lyase (HMGCL)] also exhibited
early up-regulation in LG chickens. Interestingly, the
endogenous avian leukosis virus envelope protein
(envPr57) was highly expressed in abdominal fat of
LG chickens across juvenile development (1-11 wk).
The truncated or short chicken growth hormone
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(scGH) transcript was expressed higher (P≤0.01) in
abdominal fat of HG chickens at 1 and 7 wk.
Differences in the thyroid hormone-activating enzyme,
deiodinase, iodothyronine, type I (DIO1), were seen at
3, 5 and 9 wk. (upregulated in LG chickens at all 3
ages) with the largest difference seen at 5 wk.
(7.7-fold higher in LG chickens). Conversely, the gene
for the thyroid hormone-deactivating enzyme [deiodinase, iodothyronine, type III (DIO3)] was expressed
higher in LG chickens at 1 and 3 wk., whereas DIO3
abundance was greater in visceral fat of the HG at 9
and 11 wk.
The differential expression of 46 genes identified by
RNA-Seq analyses at 7 wk. was also examined by qRTPCR at 7 wk. (Table 4). A subset of 25 DE genes, identified
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Fig. 11 Verification of differential expression of genes associated with leanness by qRT-PCR analysis. The abundance of seven genes, expressed higher in
LG birds and associated with leanness, was also verified by qRT-PCR analysis. An additional gene, short isoform of chicken GH (scGH), was included in this
figure, although its expression was higher in the HG at 7 wk. Data points represent the mean ± SE of 4 birds/genotype and age. Significant differences
between genotypes at each age were determined using one-way ANOVA and Tukey’s multiple comparisons procedure at significance levels of P≤0.05 (*)
and P≤0.01 (**). The ‡ symbol denotes a data point that approaches significance (P≤0.10)
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by microarray analysis, was included in the three-way
comparison. Eleven of these genes were significantly different (P ≤ 0.05) between HG and LG chickens across all
three methods (ALB, ALDOB, A2M, EX-FABP, FADS2,
FGA, HSD17B7, PDK4, SCD, THBS2, and TTR). Twelve
genes were significantly different (P ≤ 0.05) between HG
and LG chickens by qRT-PCR, although they did not
reach significance level by either RNA-Seq or microarray
analyses (AGTR1, ANXA1, CEBPA, F5, FASN, HPGDS,
LDHA, LPIN1, LPL, ND6, PPARG, and PYGL). Two genes
were not significantly different by qRT-PCR or RNA-Seq
analyses, but reached significance in the microarray
analysis (PLG and PGRMC1). Expression ratios of these
25 genes for qRT-PCR analysis versus microarray analysis
and RNA-Seq analysis versus microarray analysis comparisons had significant Spearman’s rank coefficients [rho
(P) = 0.824615 and 0.854395, respectively]. The additional
twenty-two genes analyzed by qRT-PCR at 7 wk. were
similar by RNA-Seq analysis in magnitude, direction of
fold change and significance level, except for four genes
(GPD1, LCN15, PDE1C and SELP), which were not
significant (P≤0.05) by RNA-Seq analysis but reached
significance by qRT-PCR analysis. Expression fold-change
ratios of forty-seven genes produced a significant
Spearman’s rank coefficient [rho (P) = 0.928789] across
qRT-PCR and RNA-Seq analyses.
Independent analysis of two RNA-Seq datasets of abdominal
fat at 7 wk. in chickens divergently selected on abdominal
fatness (FL vs. LL) or growth rate (HG vs. LG)

The two datasets from RNA-Seq analysis of abdominal fat in the high-growth (HG) versus low-growth
(LG) chickens (NCBI GEO Series Accession #
GSE49121) and the fat line (FL) versus lean line (LL)
broiler chickens (# GSE42980) were independently analyzed by the USDA-funded Animal Systems Analysis
and Modeling Center (ASBAMC) [48]. This metaanalysis of abdominal fat transcriptomes across four
distinct genotypes revealed 1500 DE genes [adjusted
P-value (≤0.05) and FDR (≤0.05)] in the HG-LG
cockerels and 653 DE genes in the FL-LL at 7 wk.
These two datasets were used as input files for
“Comparison Analysis” in IPA, which identified 97
commonly shared DE adipose genes. The top overrepresented canonical pathways found by IPA were
“Acute Phase Response Signaling, Coagulation System,
and FXR-RXR Activation”. The top gene interaction
network represented by the 97 commonly shared DE
genes in HG vs. LG (Fig. 12-a) and FL vs. LL
cockerels (Fig. 12-b) was functionally annotated by
IPA as “Cardiovascular/Hematological Disease and
Developmental Disorder”. This network was composed of a core of fibrinogenic (FGA, FGB, FGG,
HRG, and F10), fibrinolytic (PLG) and transporter
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(ALB, APOA4, and AHSG) genes which were highly
expressed in leaner chickens from either divergent
line (i.e., the LG and LL). However, the expression
pattern of several other genes in this network differed
according to genetic background. These divergent
genes include G-protein coupled receptors (CHRM2,
TRHR, TAS1R3), estrogen biosynthesis (CYP19A1),
gluconeogenesis (PCK1), retinol transport (RBP4), and
an upstream regulator of triglyceride metabolism
(CREB3L3).

Discussion
Our avian models of growth and metabolism were originally derived from a population of Bresse-Pile broiler-type
chickens, which were divergently selected by Ricard [23]
for either high (HG) or low (LG) body weight (BW) at 8
and 36 wk. Divergent genetic selection on juvenile and
adult BW for more than 30 generations has resulted in a
2.7-fold difference in BW of HG and LG cockerels
between 1 and 11 wk. (see Fig. 1-a). Perhaps more remarkable was achievement of an even greater difference in
visceral fatness, where HG cockerels are 8-fold fatter than
the LG birds during juvenile development (Fig. 1-b and c).
Thus, the divergent HG and LG chickens serve as unique
avian models to unravel the genetic basis of extremes in
fatness and leanness, which are incidental to their primary
divergence in BW [30, 32]. Divergent genetic selection on
abdominal fat alone in the FL and LL chickens has
resulted in 2.5-fold difference in visceral fatness at the
same body weight [51]. From our current analyses, we
found DE genes that were unique to abdominal fat transcriptomes of the HG and LG cockerels, while a common
set of DE genes, related to the divergence in abdominal
fatness of the HG and LG chickens, was shared with our
previous models of divergently selected FL and LL
chickens.
For example, our recent transcriptional analyses of
abdominal fat in FL and LL chickens revealed overexpression of numerous hemostasis genes in abdominal
fat of the leaner LL chickens [21, 22]. The present study
has extended this novel finding to slower-growing and
leaner LG chickens, which also show over-expression of
coagulation and fibrinogenic genes in their diminished
visceral fat. Hemostatic processes were amongst the top
canonical pathways represented by DE genes identified
by RNA-Seq and IPA analyses of abdominal fat in the
LG cockerels. We found marked up-regulation of several
hemostatic genes in visceral fat of LG chickens that
belong to both the intrinsic and extrinsic coagulation
pathways (see Fig. 6). Other overexpressed components
of the coagulation system and fibrinolysis include serine
protease inhibitors that control coagulation (SERPINA1,
SERPINB2 and SERPINF1) and major transport proteins
found in the bloodstream (A2M, ALB, GC, and TTR).
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Table 4 Differential gene expression in abdominal fat of HG and LG chickens across three analytical methods
qRT-PCR Analysis

RNA-Seq Analysis

Microarray Analysis

Gene Symbol

Fold-change

P-Value

Fold-change

P-Value

Fold-change

P-Value

ALB

−345.12

1.38E-10

−169.4

5.00E-05

−1.48

0.0100

ALDOB

2.75

0.0037

−98.8

5.00E-05

1.4

0.0004

A2M

−2.27

0.0412

−52.7

5.00E-05

−5.81

0.0009

AGTR1

−2.08

0.0035

−1.93

6.63E-04

−1.92

0.0579

ANXA1

3.4

0.0002

2.29

5.00E-05

2.52

0.1303

CEBPA

1.73

0.0302

1.44

0.0008

3.19

0.0055

F5

−3.21

0.016

−3.24

6.63E-04

−4.34

0.1336

EX-FABP

−41.12

1.22E-08

−33.07

6.63E-04

−5.78

0.0069

FADS2

4.9

0.0003

4.08

5.00E-05

2.15

0.0004

FASN

2.78

0.0033

2.02

5.00E-05

1.35

0.0003

FGA

−1929.39

8.46E-11

−282.08

5.00E-05

−7.91

0.0002

HPGDS

−2.76

0.0003

−4.57

5.00E-05

−4.05

0.0033

HSD17B7

3.38

2.21E-05

3.48

5.00E-05

5.15

0.0401

LDHA

−2.74

0.015

−2.02

5.00E-05

−1.58

0.0484

LPIN1

2.22

0.0278

1.47

0.0001

1.1

0.5185

LPL

3.69

0.0002

2.15

0.0032

1.54

0.0007

ND6

−1.78

0.037

−2.55

5.00E-05

−1.28

0.0309

PPARG

2.55

0.0047

1.70

5.00E-05

1.66

0.2626

PYGL

3.07

0.0068

2.14

0.0833

1.45

0.0052

PLG

−7.22

0.0652

−299.71

0.0001

−3.52

0.0493

PGRMC1

1.36

0.1159

1.7

1

2.42

0.0205

PDK4

−4.95

0.0056

−6.14

5.00E-05

−1.25

0.0002

SCD

89.12

0.002

129.4

5.00E-05

3.53

4.52E-13

THBS2

3.57

0.0012

2.97

5.00E-05

5.18

2.33E-05

TTR

−20.01

9.86E-07

−35.72

5.00E-05

−1.73

0.0229

DHCR24

6.18

0.0001

5.46

5.00E-05

-

-

ACACA

1.85

0.056

1.82

5.00E-05

-

-

ACE

1.91

0.0269

2.47

6.63E-04

-

-

AGT

−24.69

1.73E-06

−39.29

6.63E-04

-

-

APOH

−24.98

1.48E-06

−122,00

5.00E-05

-

-

CDS2

1.99

0.0729

1.81

6.63E-04

-

-

F8

−1.49

0.0589

−2.26

6.63E-04

-

-

DGKQ

4

1.08E-05

3.18

5.00E-05

-

-

DPP7

2.73

0.0003

2.69

0.0086

-

-

FGB

−32.54

1.11E-06

−324.53

5.00E-05

-

-

FGG

−118.03

0.0016

−197.44

5.00E-05

-

-

FZD9

1.54

0.0201

2.07

6.63E-04

-

-

GPD1

3.25

6.74E-06

1.92

5.00E-05

-

-

GREM1

2.02

0.0007

3.41

5.00E-05

-

-

IGFALS

2.13

0.0287

2.49

5.00E-05

-

-

KLF5

−3.09

0.0076

−2.70

5.00E-05

-

-

OSBP2

2.1

0.0561

2.07

5.00E-05

-

-

PDE1C

−1.84

0.0078

−2.04

5.00E-05

-

-

Resnyk et al. BMC Genomics (2017) 18:626

Page 23 of 31

Table 4 Differential gene expression in abdominal fat of HG and LG chickens across three analytical methods (Continued)
SELE

−3.28

0.0139

−7.81

5.00E-05

-

-

SELP

−2.08

0.0089

−2.74

5.00E-05

-

-

SERPINB2

−6.11

0.0035

−8.87

5.00E-05

-

-

Fold-change values [(+) is higher expression in HG and (−) is higher expression in LG chickens] provided across three independent transcriptional analysis methods at 7 wk.
P-value for qRT-PCR and microarray analyses were determined by a Student’s T-test on expression values at 7 wk. P-value for RNA-Seq is corrected for FDR (FDR ≤ 0.05)

a

Higher expression in HG
Higher expression in LG

b

Higher expression in FL

Higher expression in LL
Fig. 12 Meta-analysis of RNA-Seq analysis of abdominal fat in 7 wk.-old cockerels, which were genetically selected for a large divergence in either growth
rate (HG vs. LG) or abdominal fatness (FL vs. LL), revealed a common network of highly expressed fibrinogenic genes in the leaner lines (LG and LL). This
common gene interaction network was identified by IPA from a commonly-shared set of 97 DE genes identified by an independent analysis of visceral fat
transcriptomes in HG vs. LG (Panel a) and FL vs. LL cockerels (Panel b) at 7 wk. The two datasets from RNA-Seq analysis of abdominal fat in the high-growth
(HG) versus low-growth (LG) chickens (NCBI GEO Series Accession # GSE49121) and the fat line (FL) versus lean line (LL) broiler chickens (# GSE42980) were
downloaded and independently analyzed by the USDA-funded Animal Systems Analysis and Modeling Center (ASBAMC) [48] under an approved project
to LAC
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These plasma transporters could be important in
maintaining leanness. For example, A2M is known to
inhibit proteases (including coagulation factors) and
transport cytokines [52]. Likewise, ALB, GC, and TTR
are part of the same family of proteins that transport
metabolites associated with leanness including: steroids,
fatty acids, vitamin D [53], thyroid hormone [54] and
retinoid [55]. Numerous studies of obese humans and
murine models have demonstrated direct links between
hemostasis and development of metabolic disorders
(reviewed in [56–62]). Obese mammals present with a
prothrombotic and hypercoagulable state, which is
marked by elevated levels of thrombin in circulation.
Enhanced production of inflammatory cytokines and
adipokines in abdominal fat of obese mammals leads to
insulin resistance and impaired fibrinolysis [60, 62]. In
contrast, we have discovered over-expression of numerous coagulation genes and “ectopic” endocrine factors in
reduced abdominal fat of LL chickens, but not the FL
[21, 22]. We have proposed that these highly expressed
coagulation factors (mainly proteases and protease
inhibitors) could serve a novel role within visceral fat of
genetically lean chickens by controlling the proteolytic
activation or deactivation of adipokines or other
endocrine factors. The present transcriptional analysis of
abdominal fat in divergently selected HG and LG chickens clearly shows up-regulation of several hemostatic
genes in the diminished visceral fat of the leaner and
slower-growing LG chickens, which validates our idea
that the enhanced expression of prothrombic and fibrogenic genes in genetically leaner (LL or LG) chickens
contributes to their extreme leanness. Furthermore, we
have no indication that enhanced expression of coagulation factors in visceral fat of genetically lean chickens
would adversely affect systemic hemostasis, which
depends upon hepatic synthesis of most clotting precursors. A recent study of three breeds of chickens with
distinct differences in abdominal fatness indicates that
increased lipid catabolism and reduced lipid synthesis
within adipose tissue largely determine leanness in the
chicken [63].
The independent meta-analysis of two RNA-Seq datasets from abdominal fat of the HG and LG lines versus
the FL and LL lines at 7 wk. has revealed a common
gene interaction network of 97 shared genes that are involved in blood coagulation, endocrine signaling, and
energy metabolism (Fig. 12). The leaner (LG and LL)
chickens over-express a core set of prothrombotic (FGA,
FGB, FGG, F10 and HRG) genes, the fibrinolytic gene
(PLG), acute-phase proteins (AHSG and ORM1), and
several transporter (ALB, APOA4, HDL and LDL) genes
in their diminished abdominal fat. This common “core”
network also contains a clusters of divergently-expressed
genes related to G-protein-coupled signaling (CHRM2,
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TRHR, MLNR and TAS1R3). The sweet taste receptor
(TAS1R3) was expressed higher in abdominal fat of HG
cockerels; whereas, the TAS1R3 was up-regulated in
abdominal fat of the LL chickens at 7 wk. Previously, we
found by microarray analysis that the sweet taste receptor (TAS1R1) was expressed higher in the hypothalamus
of FL chickens at 1 wk. [64], although in visceral fat the
TAS1R1 was over-expressed in the LL chickens [21].
Furthermore, TAS1R3 knockout mice fed an adipogenic
diet present with decreased adiposity and increased bone
mass [65]. However, the mechanism by which the sweet
taste receptors contribute to diet induced obesity in
mice was not elucidated. Clearly, the role of sweet taste
receptors (TAS1R1 and TAS1R3) in regulation of energy
utilization and adiposity of the chicken and other avian
species will require further investigation.
The Del-Mar 14 K Chicken Integrated Systems microarray was used for time-course gene expression profiling
in abdominal fat of HG and LG cockerels (1-11 wk). In
particular, this custom chicken microarray [30, 31] was
well suited for functional gene discovery in abdominal
fat, since one-quarter (26%) of cDNAs printed on this
18 K-feature array were derived from abdominal fat
cDNA clones. Similar to our transcriptional analyses of
fat accretion in the divergent FL and LL cockerels [22],
RNA-Seq analysis of abdominal fat was also completed
on four HG and four LG cockerels at 7 wk., which was
the age with the largest divergence in body weight and
visceral fatness. Our time-course microarray analysis
clearly shows engagement of several pairs of DE
transcription factors in genetic divergence of growth and
abdominal fatness traits in HG and LG cockerels. For
example, PPARG has a larger number of direct gene
targets that support increased synthesis and storage of
fatty acids in visceral fat of HG cockerels, while PPARD
exerts an opposing action by inhibiting lipid synthesis
(SCD and FASN), while promoting lipolysis and fat
catabolism in the LG chickens. RNA-Seq analysis
revealed two additional opposing pairs of up-stream
regulators [SREBF1 vs. VDR and SREBF2 vs. AR], where
the AR and VDR seems to promote expression of
catabolic genes and activation of the acute phase response in the LG cockerels. In contrast, other pairs of
transcription factors [SREBF1 vs. SREBF2; and CEBPA
vs. CEBPB] seem to be complementary or even synergistic in promoting lipogenesis and angiogenesis in abdominal fat of HG cockerels. Interestingly, the PGR appears
to act similar to ESR1 in promoting growth and fat
accretion in the HG cockerels, whereas PPARD, AR and
VDR seem to support slower growth and diminished
visceral fat in the LG cockerels.
The differential expression of numerous transcription
factors and their direct target genes in abdominal fat of
juvenile HG and LG cockerels could favor either the
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fast-growing fatter phenotype (HG) or the slower-growing
leaner LG phenotype (see Additional files 6 and 7). The
major DE upstream regulators that contribute to increased
bodyweight and abdominal fatness phenotype of HG
chickens include PPARG, SREBF1, SREBF2, CEBPA, E2F4,
FOXO1, MSC, KLF9, KLF13 and THRSPA. On the other
hand, the up-regulated transcription regulators that support
reduced bodyweight and diminished visceral fatness of the
LG phenotype were PPARD, CEBPB, CALR, PITX2, CREM,
STAT5B, AR, PGR, FBXW7, KLF5, MYC and NKX2-1.
Divergent selection for slow growth in meat-type
chickens (i.e., LG) substantially inhibits fat deposition,
while enhancing catabolism of abdominal fat (see Fig. 1).
The most remarkable changes found in expression of
abdominal fat genes appear early in post-hatching
development of the LG chickens (1-5 wk.; see Fig. 11).
The long-chain fatty acid transporter (SLC27A1) was upregulated in abdominal fat of LG chickens throughout
juvenile development. This gene is highly expressed in
human adipose tissue and muscle and much lower in
tissues with lower metabolic activity, and is barely
detectable in liver [66]. The SLC27 proteins are
responsible for the cellular up-take of long chain fatty
acids for storage [67] or, more likely, for β-oxidation and
enhanced energy production in LG chickens.
Correspondingly, the rate-limiting step of β-oxidation is
controlled by CPT1A, which is highly expressed in abdominal fat of LG chickens. The over-expression of
CPT1A is driven by increased energy expenditure in
chickens, where hepatic expression is up-regulated by
fasting [68] or down-regulated after the embryo-hatch
transition [32]. Furthermore, several single nucleotide
polymorphisms were identified in CPT1A of Yup’ik
Eskimos, which exhibit fasting-lipid and obesity phenotypes [69]. After transport of long chain fatty acids to
the mitochondria, several steps of β-oxidation are catalyzed by the tri-functional protein hydroxyacyl-CoA
dehydrogenase (HADH), which produces acetyl-CoA for
entry into the TCA cycle. Both subunits of the tri-functional protein (HADHA and HADHB) were over
expressed in LG chickens from 1 to 5 wk., which
corresponds to increased expression of mitochondrial
malic enzymes (ME2 and ME3) and several subunits of
enzyme complexes in the electron transport chain.
Although most long-chain fatty acids undergo
mitochondrial β-oxidation, several substrates including
very-long-chain fatty acids, polyunsaturated fatty acids
and several others must be broken down by peroxisomal
β-oxidation. The transcript for a major enzyme involved
in peroxisomal β-oxidation, HSD17B4, was also upregulated in abdominal fat of LG chickens. Deficiency of this
enzyme in humans causes a severe developmental syndrome due to cellular build-up of long chain fatty acids
and leads to death soon after birth; whereas, knockout
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of the HSD17B4 gene in mice blocks the peroxisomal βoxidation of long chain fatty acids, without causing neonatal death [70].
Ultimately, the TCA cycle appears to be unable to handle the overload of acetyl-CoA produced by β-oxidation of
fatty acids in abdominal fat of LG chickens, causing the
over-expression of HMGCS2 and HMGCL (see Fig. 11),
the two main enzymes in mitochondrial ketone body synthesis. The expression of HMGCS2 transcripts is greatly
induced by fasting in the liver of suckling piglets [71] and
4-week old chickens [68]. In humans, both HMGCS2 and
HMGCL exhibit alternative splicing which could regulate
their tissue-specific expression [72]. Whether or not this
complex regulation exists among different tissues in
chickens has not been determined. Proprotein convertase
subtilisin/kexin type 1 (PCSK1) is another candidate gene,
whose expression was 2.2-fold higher in visceral fat of the
LG cockerels (Additional file 5). Inhibitors of another
members of this gene family, PCSK9, show great promise
as a new therapeutic intervention to control hypercholesterolemia and promote cardiovascular health in humans
[73]. Taken together, these findings support the idea that
LG chickens increase cellular fatty acid up-take, peroxisomal β-oxidation, and transport to/into the mitochondria
for β-oxidation and usage in the TCA cycle during early
(1-5 wk) development, driving their divergence in abdominal fatness.
The LG chickens appear to down-regulate the mitochondrial breakdown of pyruvate through up-regulation
of PDK4, which inhibits the pyruvate dehydrogenase
(PDH) complex. PDH activity increases with increasing
skeletal muscle stimulation (increasing contraction intensity) to a much greater extent in PDK4 knockout
mice than in controls, which suggests that PDK4 is
essential for preventing over-activation of the PDH complex [74]. Along with exercise, PDK4 is over-expressed
in rodents subjected to high fat diet or fasting [75],
which is similar to what is seen in chickens where both
fasting and acute insulin immunoneutralization cause
up-regulation when compared to the fed controls [76].
Furthermore, PDK4 appears to be crucial pre-hatch for
the acquisition of stored energy, since its expression is
quite high between embryonic day e16 and e20, then
drops dramatically at hatch and remains low from day 1
through 9 post hatch [32].
Several transcriptional modulators (RELA, CALR,
FBXW7, NR1I3, NR4A3 and PIAS1) inhibit transcription
of genes involved with increased adiposity (SCD, FASN,
DGAT2, FABP4, PCK1, LPL, PPARG, CEBPA, etc.;
discussed below), while activating genes associated with
leanness (COX1, HSD17B4, DIO1, etc.). For example,
PIAS1 suppresses LXR activation of fatty acid synthesis
in murine hepatocytes [77] and NR1I3 is associated with
hepatic ω-fatty acid oxidation in quercetin-fed mice [78].
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Gene expression of type 1 iodothyronine deiodinase
(DIO1), the major enzyme responsible for the conversion
of the pro-hormone T4 to metabolically-active T3, and
DIO3, which degrades active T3 and converts T4 to inactive reverse T3 (rT3) [79] were examined by qRT-PCR
analysis (see Fig. 11). Interestingly, DIO1 appears to be
over-expressed in LG chickens during early juvenile
development (3-7 wk), while expression of the degrading
enzyme DIO3 is higher in HG chickens at later ages (9
and 11 wk). This could provide higher levels of T3 in
abdominal fat of LG chickens throughout juvenile
development, which would contribute to their leanness
[54]. The nuclear hormone receptor PPARD (see Fig. 2)
has similar activation and inhibition targets and directly
up-regulates several additional genes associated with
leanness (i.e., ANGPTL3, PLP1 and PDK4). Selective
knock-in of PPARD in adipose tissue of Lepdb/db mice
reduces lipid accumulation and prevents obesity in mice
[80]. Early (1 to 5 wk) up-regulation of PPARD in
abdominal fat of LG chickens and its direct action on
target genes suggest that PPARD is a major regulator of
lipolysis in these leaner and slower growing animals.
Presently, we show that HG cockerels over-express
many genes controlling adipogenesis and lipogenesis in
visceral fat (see Figs. 2 and 4; Table 4), which seems
against the convention that abdominal fat only makes a
minimal contribution to lipogenesis in the chicken [81].
This finding is supported by our earlier studies that
show enhanced expression of genes controlling these
processes in abdominal fat of fat line (FL) chickens [21].
Upregulation of adipogenesis and lipogenesis in abdominal fat of HG chickens is likely supported by increased
activity and interaction of several transcription factors,
including PPARG [82], CEPBA [83], SREBF1 [84] and
THRSPA [85, 86]. These transcriptional regulators are
over-expressed throughout juvenile development and
control common lipogenic targets, including DGAT2,
FADS2, FASN and SCD (discussed below). Furthermore,
IPA predicts the up-regulation of an additional 13
transcriptional regulators associated with fatness of
HG chickens, which also directly increase the expression of lipogenic genes and other genes associated
with fatness (see Additional files 6 and 7). Microarray
analysis of liver in transgenic mice over-expressing
SREBF1 or SREBF2 show that they have many common targets and both regulators play a crucial role in
synthesis and metabolism of fatty acids and cholesterol [87]. Currently, our microarray and RNA-Seq
analyses of abdominal fat in the HG and LG chickens
show that SREBF1 and SREBF2 support increased
growth rate and abdominal fatness of HG cockerels.
These ligand-activated transcription factors enhance
lipogenesis as indicated by their over-expression in HG
chickens and direct redundant activation of numerous
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target genes controlling lipid metabolism (CYB5A,
DHCR7, FADS2, FASN, INSIG1, LSS, MSMO1, PCYT1A,
SC5D, SCD and SQLE) (see Fig. 7-b).
INSIG1, also higher in HG chickens, may be a
major regulator of fatty acid and cholesterol synthesis
through the direct regulation of the SREBF chaperone
(SCAP), and HMG-CoA reductase [88]. Two
additional genes involved in cholesterol synthesis
(DHCR24 and HSD17B7) are commonly up-regulated
by divergent selection for high body weight or high
abdominal fatness [21]. The expression of DHCR24 in
whole blood was highly correlated and decreased with
weight loss after bariatric surgery in humans [89].
Two other genes which are over-expressed in adipose
tissue of HG chickens, ACACA and ACSS2, were
identified as predictors of weight loss in another
group of patients who underwent bariatric surgery,
where decreased expression in adipose tissue was
associated with a decrease in weight and hip circumference [90]. Acetyl CoA carboxylase (ACACA or
ACC1) is critically important for the generation of
malonyl CoA and synthesis of long chain fatty acids.
This was demonstrated in human hepatoma HepG2
cells where inhibition of ACC1 by soraphen A reduces de novo lipogenesis by attenuating the formation of malonyl CoA and long chain fatty acids [91].
Overexpression of fatty acid elongases, ELOVL5 and
ELOV6, or desaturases, FADS1 and FADS2 were not
successful in reversing the effect of soraphen A on
production of long chain fatty acids, which supports a
crucial role of ACC1.
Perhaps one of the most significant findings of
abdominal fat transcriptomes in the HG and LG
chickens was a very large difference in expression of
SCD, the rate-limiting enzyme responsible for conversion of saturated fatty acids into monounsaturated
fatty acids. At 7 wk., SCD was the highest-expressed
gene found in abdominal fat of HG chickens (see
Fig. 10-b), where its expression was approximately
140-fold greater than that of the LG. This large difference was present throughout juvenile development
(1-11 wk), where SCD transcripts were nearly
undetectable in abdominal fat of LG chickens.
Mutation of the SCD gene in mice produces a lean
and hyper-metabolic phenotype, while ob/ob mice
that also carrying mutations in SCD exhibit reduced
fatness and elevated metabolism [92]. Another desaturase expressed very highly in abdominal fat of HG
chicken is FADS2, which is down-regulated in liver
in response to fasting in both pigs [93] and chickens
[68], as well as in the pre-hatch chick embryo [32].
The major multi-enzyme protein responsible for the
synthesis of fatty acids, FASN, is also very highly
expressed in HG chickens at several ages, with the
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peak difference observed at 7 wk., the age of maximal distinction in abdominal fat between the two
genotypes. The essential role of FASN in the fatty
acid biosynthesis is highlighted in mouse embryos
where FASN knockout mice die before birth and heterozygous knockout mice die at various stages of development [94]. An incredibly similar expression
pattern (as FASN) was observed for DGAT2, which
was almost 10-fold higher in HG chickens at 7 wk.
DGAT2 catalyzes the final committed step in triacylglycerol synthesis and is critical for formation of
adipose tissue [95, 96]. Overexpression of DGAT2 in
mammalian HEK293 cells significantly increases
triglyceride (TG) synthesis while inhibition of
DGAT2 by compound 122 decreases TG synthesis in
a dose dependent manner [97]. Further, DGAT2 is
up-regulated in goose hepatocytes exposed to a mixture of long chain fatty acids [98]. Correspondingly,
ACSL1, which generates fatty acyl-CoA for entry into
the triacylglycerol synthesis pathway, and AGPAT9,
which catalyzes the conversion of glycerol-3phosphate to lysophosphatidic acid, the initial step
of triacylglycerol synthesis [99] were both overexpressed in HG chickens. Abdominal fat of HG
chickens also over expresses GPD1, which serves as
a link between carbohydrate metabolism and lipid
metabolism by catalyzing the conversion of dihydroxyacetone phosphate to glycerol-3-phosphate, the major
component of glycerophospholipids. In fact, HG chickens
up-regulate several genes involved in glycolysis including
hexokinase 1 (HK1), which phosphorylates glucose to
produce glucose-6-phosphate, the first step in the glycolytic pathway, and ALDOB, which converts fructose
1,6-bisphosphate into glyceraldehyde 3-phosphate and
dihydroxyacetone phosphate (substrate for GPD1). Taken
together, HG chickens up-regulate genes required for
production of acetyl-CoA used in biosynthesis of fatty
acids, cholesterol and triglycerides, which are highly upregulated processes in the abdominal fat of these animals.
Another important observation from the present transcriptional study was the predominate overexpression of
avian leukosis virus (ALVE or envPr57 polyprotein) transcripts in the LG chickens across all ages (1-11 wk) and tissues (pituitary, abdominal fat, liver and breast muscle)
examined [32]. The abundant overexpression of endogenous envPR57 transcripts in abdominal fat of LG cockerels
during juvenile development (1-11 wk) was verified by
qRT-PCR analysis (Fig. 11). It is of particular interest that
ALVE transcripts are also highly-expressed in the
hypothalamus [10], brain and peripheral tissues of the lowweight strain (LWS) chickens developed at Virginia Tech,
particularly in immature pullets [6, 11], where a greater
number of ALVE integration sites are found in LWS pullets
when compared to high-weight (HWS) females. These

Page 27 of 31

authors concluded that ALVE sequences might directly
affect growth or could be linked to loci regulating growth.
The relationship between the multiple ALVE loci and genetic selection of production traits was examined in several
meat-type chickens [100, 101]. Although our HG and LG
lines were divergently selected from the Bresse-Pile breed in
France [23] and the Virginia HWS and LWS lines were independently selected from the White Plymouth Rock breed.
It is not known whether the higher abundance of ALVE in
the low-growth (and low abdominal fatness) lines could reflect inheritance from a common ancestor or a direct response of selection for low growth. It is possible that the
high frequency of ALVE insertion sites in the genome of
meat-type chickens could disrupt key functional genes controlling growth or metabolism traits.
Lastly, we found evidence for a divergence in growth
hormone (GH) signaling in the divergently selected HG
and LG cockerels. Plasma levels of pituitary GH are elevated 2.5-fold in LG chickens, whereas plasma IGF-1
levels are 3-fold higher in the faster-growing and fatter
HG birds (Duclos MJ, Simon J and Cogburn LA;
unpublished observations). The LG cockerels also exhibit
diminished GH binding to hepatic GH receptors (GHR),
which seems to reflect the subsequent lack of negative
feedback control on GH secretion from the pituitary
gland. Thus, the reduced growth rate of LG chickens
reflects a disruption in GHR signaling as evidenced by a
reduction in hepatic synthesis of IGF-I and low plasma
IGF-I levels [29]. Presently, we found a greater abundance
of the small chicken GH (scGH) in abdominal fat of HG
chickens at 7 wk. when compared to LG birds (see Fig. 11).
The scGH was originally identified in the eye of chick embryos [102] and apparently exerts a local action in ocular
tissue via an autocrine or paracrine action, since the signal
sequence is absent [103–105]. Earlier, we identified a similar truncated cGH transcript in adipose tissue of the
chicken from an exhaustive expressed-sequence tag (EST)
sequencing project [106]. Insulin-like growth factor (IGF)
signaling could be up-regulated in visceral fat of HG
chickens, since IGFBP2 is over-expressed in abdominal fat
of HG birds. Interestingly, IGFBP2 is primarily secreted
from adipocytes and diminishes with childhood obesity
[107]. Clearly, further studies on GH and IGF signaling in
chicken adipose tissue are needed to fully understand how
GH and IGF-1 contribute to lipogenesis and adiposity of
chickens. Our earlier studies clearly show that exogenous
GH increases abdominal fatness in juvenile chickens without affecting growth rate or plasma IGF-1 levels [108–112],
which is unlike the typical mammalian response to exogenous GH [113–115].

Conclusions
Divergent selection for bodyweight at two ages (juvenile
and adult) in meat-type chickens has profound effects on
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abdominal fatness and body weight traits (phenotypes).
Throughout juvenile development, visceral fat of HG
chickens over-express several transcription factors, which
promote lipogenesis and adipogenesis. These regulators of
transcription appear to be responsible for the up-regulation of several processes (i.e., biosynthesis of fatty acids,
cholesterol and triglycerides) that increase abdominal fatness in HG cockerels. These lipogenic genes are not only
differentially expressed, but are also among the most
abundant transcripts found in abdominal fat of the HG.
During early juvenile (1-5 wk) development, the slower
growing and leaner LG chickens increase expression of
several genes that promote energy expenditure, which
likely contributes to their extreme leanness (i.e., oxidative
phosphorylation, peroxisomal β-oxidation, mitochondrial
β-oxidation and ketogenesis). Also, the expression of functional energy-consuming genes could be altered by the
ALVE protein itself or random viral ALVE insertions,
found throughout the chicken genome, could disrupt gene
expression. Up-regulation of hemostatic factors (proteases
and protease inhibitors) appears critical to development of
extremes in leanness found in LG and LL chickens derived
from different genetic backgrounds. This lends support to
the idea that genetic selection for a divergence in growth
or fatness traits also provides insight into mechanisms
controlling fatness and leanness phenotypes. Metaanalysis of two RNA-Seq datasets from abdominal fat in
divergently selected chickens from two distinct genetic
backgrounds provides novel evidence that adipose genes
encoding coagulation proteins are associated with the lean
phenotype in meat-type chickens. While the exact mechanisms by which hemostatic genes contribute to leanness
in chickens have not been clearly defined, the present
transcriptional study of abdominal fat in HG and LG
cockerels validates our previous reports that describe involvement of the hemostasis system in limiting adiposity
of the leaner (LL) chickens [21, 22]. Furthermore, the
present study demonstrates that abdominal (visceral) fat
of the chicken is a dynamic metabolic and endocrine tissue, which has an unappreciated capacity for in situ
lipogenesis.

Additional files
Additional file 1: Microarray experimental design. A Microsoft Excel file
containing a single work sheet “Array Hybridization Design” which
described the hybridization scheme for the HG and LG adipose tissue
microarray experiment. (XLSX 13 kb)
Additional file 2: Primer information. A Microsoft Excel file containing a
single work sheet “Primer information”. For each primer used for qRT-PCR
analysis, gene symbol, gene name, forward and reverse primer sequences, GenBank accession, and amplicon size (bp) are provided. (XLSX
20 kb)
Additional file 3: Differentially expressed (DE) genes identified by timecourse microarray analysis of abdominal fat in HG and LG cockerels (1-11 wk).
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A Microsoft Excel file containing three worksheets representing the main effect
of genotype (G), the main effect of age (A), and the G x A interaction. The G, G
x A interaction and combined unique (G plus G x A gene lists) datasets were
used for Ingenuity Pathway Analysis (IPA). (XLSX 484 kb)
Additional file 4: Power analysis of the HG and LG abdominal fat RNASeq dataset. (A) The publically available web-based software program
called “Scotty” [49, 50] was used for a power analysis to demonstrate
adequate biological samples size and sequencing depth. The power of
detection was calculated at ≥1.5, 2, or 3-fold change differences between
HG (N = 4) and LG (N = 4) chickens at a significance level of P≤0.05 and
>50 M reads per biological sample. We achieved the power to detect
70% genes with a ≥1.5-fold difference as indicated by the red dashed
line. (B) The “Scotty” program also provided a hierarchical cluster analysis
using the Spearman correlation as the distance metric to demonstrate
relatedness among the eight individual (4 HG and 4 LG) birds used for
RNA-Seq analysis of abdominal fat at 7 wk. (PPTX 352 kb)
Additional file 5: Differentially expressed (DE) (FDR ≤0.05) identified by
RNA-Seq analysis of abdominal fat in HG and LG cockerels (7 wk). A
Microsoft Excel file containing one worksheet. (XLSX 277 kb)
Additional file 6: Top pathways and biological functions identified by
IPA from time-course microarray analysis of abdominal fat in HG and LG
cockerels (1-11 wk). A Microsoft Excel file containing eight worksheets
[i.e., “Upstream Regulators, Oxidative Phosphorylation, LXR/RXR Activation,
Fatty Acid Metabolism, Adipogenesis Pathway, Insulin Resistance, VEGF
Signaling, and Protein Metabolism”]. Top canonical pathways and
biological functions were identified by Ingenuity Pathway Analysis (IPA)
of 647 “Analysis Ready” (AR)-DE genes (FDR ≤ 0.05) from time-course
(1-11 wk) microarray analysis. (XLSX 49 kb)
Additional file 7: Top canonical pathways and biological functions
identified by Ingenuity Pathway Analysis of RNA-Seq analysis of abdominal fat
in HG and LG cockerels (7 wk). A Microsoft Excel file containing 10 worksheets
of the DE genes assigned by Ingenuity Pathway Analysis to top canonical
pathways and biological functions [i.e., “Upstream Regulators, Acute Phase
Signaling, Coagulation System, Intrinsic Prothrombin Activation, Extrinsic
Prothrombin Activation, LXR/RXR Activation, Fatty Acid metabolism, Adipogenesis
Pathway, Insulin Resistance, VEGF Signaling, and Protein Metabolism”].
(XLSX 81 kb)
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